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ABSTRACT 
In murine and human brown adipose tissue (BAT), mitochondria are powerful 
generators of heat. Emerging evidence has suggested that the actions of mitochondria 
extend beyond this conventional biochemical role. In mouse BAT and cultured brown 
adipocytes, impaired mitochondrial respiratory capacity is accompanied by attenuated 
expression of Ucp1, a key thermogenic gene, implying a mitochondrial retrograde 
signaling. However, few have investigated this association in the context of 
mitochondria-nucleus communication.  
Using mice with adipose-specific ablation of LRPPRC, a regulator of respiratory 
capacity, we show that respiration-dependent retrograde signaling from mitochondria to 
nucleus contributes to transcriptional and metabolic reprogramming of BAT. Impaired 
respiratory capacity triggers down-regulation of thermogenic and oxidative genes, 
promoting a storage phenotype in BAT. This retrograde regulation functions by 
interfering with promoter-specific recruitment of PPAR. In addition, cytosolic calcium 
may mediate the retrograde signal from mitochondria to nucleus. These data are 
consistent with a model whereby BAT connects its respiratory capacity to thermogenic 
gene expression, which in turn contributes to determining its metabolic commitment.  
Additionally, we find that augmented respiratory capacity activates the 
thermogenic gene program in inguinal (subcutaneous) white adipose tissue (IWAT) from 
adipose-specific LRPPRC transgenic mice. When fed a high-fat diet at thermoneutrality, 
these mice exhibit metabolic improvements as shown by reduced fat mass and improved 
insulin sensitivity. Furthermore, there is increased recruitment of brown-like adipocytes 
vii 
 
in IWAT and thus energy expenditure is significantly increased, providing a potential 
explanation for protection from obesity. These data suggest that augmented respiratory 
capacity promotes ‘browning’ of IWAT, which has beneficial effects on obesity and 
diabetes. 
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CHAPTER I 
INTRODUCTION 
 
1.1. Brown adipose tissue (BAT) 
Brown fat is mainly composed of thermogenic adipocytes that convert chemical 
energy to heat. Found in homeothermic animals such as mammals, brown fat protects 
against cold stress. In neonates and hibernating mammals, brown fat plays a critical role 
in thermoregulation. The first description of brown fat was made by Swiss researcher 
Gessner who wrote a report regarding the anatomy of the Alpine marmot (Marmota 
marmot) in 1551. In this report, he described interscapular brown fat as being ‘neither fat 
nor flesh’ (nec pinguitudo, nec caro) (1). In the early 1900s, although brown fat was 
commonly termed as ‘hibernating gland’ due to its presence in nearly all hibernating 
mammals and resemblance of its appearance to a gland, researchers believed that it was a 
type of adipose tissue (2). It was mid-1900s that the mysterious gland-like adipose tissue 
was found to function as a heat-producing (thermogenic) organ (3).  
There are two types of thermogenic adipocytes: classical brown adipocytes and 
beige/brite adipocytes. Classical brown adipocytes exhibit constitutive thermogenic 
capacity with large numbers of mitochondria. Developmentally programmed brown fat 
such as the rodent interscapular depot consists of these cells. Another type of 
thermogenic adipocytes is found in white fat, especially in the rodent subcutaneous depot.  
These cells are recruited by thermogenic stimuli and in turn display comparable 
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thermogenic capacity to classical brown adipocytes (4-7). Due to these properties, they 
have been named beige/brite (brown-in-white) adipocytes (8, 9). Although these two 
forms of adipocytes share thermogenic function, they are distinguished from each other 
in some ways. This distinction is clearly exemplified in their gene signatures. Zic1, Eva1 
and Epsti1 are highly expressed in classical brown adipocytes whereas Tbx1, Cd137 and 
Tmem26 are enriched in beige adipocytes (10-12). Given different patterns of gene 
expression in various depots of adipose tissue (13), this is not surprising and likely 
reflects different regulatory pathways and distinct developmental origins. Indeed, 
although exceptions exist, classical brown adipocytes are shown to largely originate from 
Myf5
+
 precursor cells that are shared with skeletal muscle whereas beige adipocytes are 
differentiated from Myf5
-
 precursor cells (14).  
The heat-generating process mediated by brown fat is often termed non-shivering 
thermogenesis that involves dissipation of chemical energy as heat (Figure 1.1). The 
thermogenic capacity of brown fat is attributed to abundant mitochondria in which heat is 
generated via uncoupled respiration (9). For this purpose, brown fat uniquely expresses 
protonophoric protein, uncoupling protein 1 (UCP1). Localized to the inner membrane of 
mitochondria, activated UCP1 provides an alternative route for proton to flow back into 
the matrix, a process that uncouples respiration from ATP synthesis, resulting in 
conversion of energy stored in proton gradient to heat in stimulated brown fat. High 
sympathetic innervation of brown fat ensures swift activation of the tissue and cold 
defense (15, 16). Brown fat is also intensively vascularized to support blood warming and 
prompt delivery of warmed blood to the periphery as well as to meet high demands for  
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Figure 1.1. Brown fat-mediated thermogenesis. Brown fat mitochondria are generators 
of heat. In the normal state, they produce ATPs as mitochondria in other tissues do. ATP 
inhibits UCP1 to block futile proton cycle, which ensures coupled respiration. When 
exposed to cold, BAT-connected sympathetic nerve system releases catecholamines such 
as norepinephrine. Norepinephrine in turn activates G protein-coupled 3-adrenergic 
receptor signaling through cAMP-PKA pathway. This pathway promotes lipolysis and 
released free fatty acids are oxidized in mitochondria to create proton gradient via 
electron transport chain (ETC). Glucose and free fatty acids from extracellular sources 
are also taken up via their transporters and utilized. In addition to their role as fuel, fatty 
acids are required to overcome ATP-mediated inhibition of UCP1. Activated UCP1 then 
uncouples respiration from ATP synthesis, which dissipates the energy stored in proton 
gradient as heat. BAT contains a large number of these heat-producing mitochondria to 
provide defense against cold. 
4 
 
oxygen supply during uncoupled respiration (17). Calculations have suggested that fully 
activated brown fat dissipates about 300-400 W/kg of energy as heat compared to 1 W/kg 
in other tissues (18-20). This high thermogenic capability necessitates robust fuel 
oxidation. Two major carbon sources—glucose and fatty acids—are used by brown fat 
for uncoupled respiration. During cold exposure, the uptake of glucose and free fatty 
acids (FFAs) and lipolysis are greatly increased (21-23). The uptake rate of each substrate 
is greater than that of skeletal muscle (22, 23), which potentially makes brown fat an 
important metabolic sink. With its energy-burning property and ability to clear excess 
nutrients, brown fat thus holds promise as a target to treat various metabolic diseases 
such as obesity, diabetes and hyperlipidemia (22, 24-26).  
Over the last few decades, the transcriptional network that drives adipocyte 
differentiation (adipogenesis) has been revealed. Using a white adipogenic cell line, 3T3-
L1 preadipocytes, researchers have identified key transcription factors of adipogenesis 
including CCAAT/enhancer binding protein (C/EBP) alpha, beta and delta and 
peroxisome proliferator-activated receptor (PPAR) gamma (27-30). Importantly, C/EBP 
and PPAR coordinately acts to induce adipocyte-specific genes, resulting in terminally 
differentiated adipocytes (28, 31, 32). Brown adipocytes also share these major regulators 
for their development. However, for their thermogenic profile, several additional factors 
must be involved. A well-known example is PPAR coactivator 1 (PGC-1) family. PGC-
1 was first identified as a cold-inducible interacting partner of PPAR, which was 
responsible for cold-induced expression of UCP1 (33). PGC-1 is also well established 
as a major driver of mitochondrial biogenesis (34). Another family member PGC-1 was 
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later identified (35), and both family members are required to activate thermogenic and 
oxidative gene program in brown adipocytes (36). A continuing search for transcriptional 
regulators that control brown fat-specific gene program identified PR Domain-containing 
protein 16 (PRDM16). PRDM16 is a nuclear protein containing zinc-finger domains (37). 
Despite its potential DNA-binding ability, PRDM16 turned out to control brown fat-
selective genes by interacting with and co-activating transcription factors C/EBP and 
PPAR . Additionally, PRDM16 plays a role in maintaining brown fat identity by 
repressing white fat-specific genes. This is achieved by forming a transcriptional 
repressor complex with CtBP1 and CtBP2 (39).  Early B-Cell Factor 2 (EBF2) is an 
example of playing a dual role in brown fat development. Enriched in brown 
preadipocytes, EBF2 recruits PPAR to brown fat-specific genes to induce brown fat 
phenotype during differentiation (40). Furthermore, EBF2 has a central role in brown 
preadipocyte commitment by regulating genes enriched in brown preadipose cells (41). 
These combinatorial transcriptional pathways allow for unique gene signatures that 
support thermogenic function. UCP1, a key thermogenic protein, is exclusively expressed 
in brown fat. Cell death-inducing DFFA-like effector a (CIDEA), a modulator of UCP1, 
and Type II iodothyronine deiodinase (DIO2), an enzyme that converts T4 to active T3 
within the tissue locally, are among major thermogenic genes (42-44). Fatty acid 
oxidation (FAO) genes and electron transport chain (ETC) subunit genes are also 
enriched (45, 46).  
Humans have brown fat as well. In humans, brown fat can be found in the 
interscapular region in infants, and interscapular, supraclavicular, axillary, neck and 
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suprarenal regions in children and adolescents (47, 48). In adults, however, brown fat has 
long been thought to regress with exceptions of those who live in extreme cold and 
patients with pheochromocytoma characterized by hypersecretion of catecholamines (49-
52). Although non-shivering thermogenesis (brown fat-mediated) is critical in infants due 
to their limited shivering capacity and rapid heat loss caused by larger surface-to-volume 
ratio, human lifestyles (clothing, shelter, etc), smaller surface-to-volume ratio and 
enhanced ability to shiver  may direct disappearance of brown fat with age. However, 
with the advent of 18F-FDG PET/CT imaging in oncology, researchers coincidentally 
detected high glucose uptake around supraclavicular region (53-56). Tissue biopsy 
confirmed multilocular and UCP1
+
 cells, indicating the existence of functional brown fat 
in healthy human adults. Several follow-up studies show that the types of thermogenic 
adipocytes vary depending on anatomical sites. Two reports suggest that supraclavicular 
human brown fat has molecular features identical to brite/beige fat (10, 57). Another 
group reported molecular signatures of deep neck fat are virtually identical to ‘classical’ 
brown fat of mice while beige-like cells exist in more superficial neck depot (58). Still 
another group reported molecular signatures intermediate between brown and beige fat 
(59). The discovery of active brown fat in adults has opened a new era of brown fat 
research and rekindled an old interest in brown fat as a potential target to treat metabolic 
diseases. 
 
1.2. Features of brown fat mitochondria 
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In murine and human brown fat, mitochondria are powerful generators of heat 
that safely metabolize fat, a feature that has great promise in the fight against obesity and 
diabetes. Brown fat mitochondria fulfill their duty as cellular powerhouses in the non-
stimulated state. In sympathetically stimulated brown fat, UCP1 is rapidly activated and 
uncouples electron transit and ATP production. Instead, the chemical energy stored in the 
proton gradient is dissipated as heat. To conduct this specialized task, brown fat 
mitochondria possess numerous distinct features. The sections below discuss the current 
knowledge of brown fat mitochondria. 
 
1.2.1. Morphological features 
Brown fat mitochondria are dynamic organelles that meet the thermogenic needs 
of the organism by regulating their number and networking as well as their biochemical 
and ultrastructural profile. Acute cold exposure (or activation with norepinephrine) 
immediately promotes mitochondrial fission, an event that precedes and augments 
thermogenesis (60). Brown fat mitochondria exhibit unique morphological features 
(Figure 1.2). Notably, brown fat mitochondria are enlarged and densely packed with 
respiratory units, resulting in dense cristae (61). The morphological features of brown fat 
also differ across gender with females having larger mitochondria and denser cristae (62). 
The density of brown fat mitochondria is among the highest of any tissue (63). Even so, 
chronic cold exposure increases mitochondrial mass even further. This is mediated by 
catecholamines via -adrenergic signaling, which increases PGC-1, a transcriptional 
coactivator that induces ERR and NRF-1, culminating in increased mitochondrial mass  
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Figure 1.2. Electron microscopic image showing ultrastructure of brown fat 
mitochondria. Shown are tightly packed lamellar cristae where high density of the 
electron transport chain resides. Magnification, 43,000x. Scale bar, 200m. 
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(33, 34, 64).  
 
1.2.2. Biochemical features 
 Early biochemical and functional studies on brown fat mitochondria in rodents 
revealed high cellular respiration but low ATP synthase activity (65). This implied that 
pathway involving proton leakage must underlie the basis of thermogenesis. Biochemical 
studies identified that UCP1 constitutes the molecular basis for enhanced proton leak (66). 
Interestingly, in larger mammals such as lambs the abundance of ATP synthase is higher 
(67), presumably because larger animals are less dependent on non-shivering 
thermogenesis due to their smaller surface-to-volume ratio and due to their increased 
capacity for shivering. 
Long chain free fatty acids (LCFAs) activate UCP1, while purine nucleotides 
inhibit UCP1 (68, 69). Intuitively, mobilization of free fatty acids via -adrenergic 
activation is coupled to UCP1 activation and heat production. Fedorenko et al reported 
that UCP1 does not exhibit constitutive proton transport activity (70). Instead, there is 
obligatory binding of LCFAs to UCP1, a process that transfers protons associated with 
LCFA into the matrix via a conformational change of UCP1. LCFAs can also overcome 
inhibition by purine nucleotides. This is important because in the basal state there is no 
robust lipolysis and inhibition of UCP1 by purine nucleotides will promote coupled ATP-
generating respiration.  
In theory, uncoupling should de-energize brown fat mitochondria, culminating in 
an ATP crisis. ATP, however, is required for activation of fatty acids during uncoupling. 
Lipid droplet 
Cytoplasm 
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Brown fat mitochondria circumvent this by increasing glycolysis as well as the TCA 
cycle. Arsenite, an inhibitor of pyruvate dehydrogenase complex (PDC) and -
ketoglutarate dehydrogenase, depleted ATP in norepinephrine-stimulated brown 
adipocytes, implying that the TCA cycle is critical for maintaining ATP during 
thermogenesis (71). Although succinyl-CoA synthetase primarily generates GTP, this 
TCA enzyme complex can also generate ATP, a process which may explain how the 
TCA cycle is critical for maintaining ATP in brown fat (discussed further in 1.2.3). 
Glycolysis is an important source of ATP as well. Notably, hexokinase activity increases 
4-fold in cold acclimated rats, achieving glycolytic activity similar to liver (72). 
 
1.2.3. Proteomical features 
Mass spectrometric analysis of mitochondria in mouse brown fat has revealed 
striking proteomic difference compared with white fat mitochondria (45). In fact, the 
proteomic profile of brown fat mitochondria was most similar to that of skeletal muscle. 
Compared with white fat mitochondria, there was an enrichment of catabolic pathways 
including electron transport chain, TCA cycle and fatty acid metabolism in brown fat 
mitochondria. Complexes I-IV are present at higher levels, whereas complex V is present 
at lower levels, a pattern favorable for thermogenesis. There is robust expression of 
enzymes involved in the TCA cycle—ADP-forming succinyl-CoA synthetase subunit 
(A-SCS-, pyruvate dehydrogenase kinase 4 (PDK4) and pyruvate dehydrogenase 
phosphatase regulatory subunit (PDPr). SCS converts succinyl-CoA to succinate. This 
reaction is coupled to the formation of ATP or GTP, which is determined by two different 
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 subunits, ADP-forming and GDP-forming. In mouse, rat, and human, metabolically 
active tissues such as brain and heart express high levels of ADP-forming subunits 
compared with GDP-forming subunits (73). Likewise, brown fat mitochondria may 
preferentially use A-SCS- to supply ATP, a feature that matches a role of substrate-level 
phosphorylation in stimulated brown adipocytes. During cold exposure, lipid uptake and 
lipogenesis replenish fat stores that have been oxidized (74). Control of lipogenesis 
during cold exposure is complex and partly regulated by pyruvate metabolism (74, 75). 
Pyruvate can be targeted for complete oxidation by converting it into acetyl-CoA via the 
enzymatic action of PDC (76). Alternatively, inhibition of PDC by PDK4 diverts 
pyruvate into glycerol, which is the backbone for FFA esterification (76). An enzymatic 
complex consisting of PDPr counteracts the action of PDK4, and thus, targets pyruvate 
for complete oxidation (77, 78). In summary, opposing regulation by PDK4 and PDP 
may play a critical role in whether or not the brown adipocyte uses pyruvate for 
lipogenesis (PDK4-mediated) or complete oxidation (PDPr-mediated).  
Fatty acids serve as major substrates for thermogenesis and they activate UCP1 
(79). In brown fat, there is high expression of enzymes involved in fatty acid oxidation, 
including short-, medium-, long-chain acyl-CoA dehydrogenases and 3-ketoacyl-CoA 
thiolase (45). Long-chain fatty acids require a carnitine palmitoyltransferase 1B 
(CPT1B)-mediated carnitine shuttle for oxidation in mitochondria. Supporting a role for 
robust oxidative capacity in brown fat, CPT1B is 50-fold higher in brown fat compared 
with white fat (45). Brown fat may also exhibit metabolic flexibility in fuel utilization. 
Highly expressed in brown fat, acetyl-CoA synthetase 2-like (ACSS1) permits oxidation 
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of ketone bodies during starvation (45, 80, 81). Indeed, activity of ketone body oxidizing 
enzymes in brown fat parallels that of the heart (82). 
A comparative proteomic analysis of human neck brown fat vs. neighboring 
subcutaneous white fat reveals a similar enrichment of mitochondrial oxidative 
metabolism pathway to mouse brown fat (83). An interesting finding is that 
mitochondrial creatine kinases are abundantly expressed in neck brown fat compared 
with subcutaneous white fat (83). This enzyme converts creatine to phospho-creatine at 
the expense of ATP, thus yielding ADP. The mitochondrial creatine kinases also plays a 
central role in forming the ‘mitochondrial interactosome’ by connecting voltage-
dependent anion channel (VDAC) in the outer mitochondrial membrane with adenine 
nucleotide translocase, phosphate transporter, phosphate transporter and ATP synthase 
(Complex V) in the inner mitochondrial membrane (84). The role of this energy unit is to 
ensure a high efficiency of ATP synthesis by concentrating molecules necessary for the 
process. Indeed, the components of this coupled respiration machinery are highly 
expressed as well in human neck brown fat, which runs contrary to mouse brown fat (83). 
Although it remains elusive, abundance of this ATP-generating supercomplex in human 
brown fat may be in parallel with the dependence of mouse beige adipocytes on a 
creatine-driven substrate cycle for energy expenditure and thermogenesis (85).  
 
1.3. Mitochondria-nucleus communication in BAT  
The endosymbiotic theory suggests that eukaryotic mitochondria are derived from 
prokaryotes engulfed in others about 1.5 billion years ago. Since then, mitochondria have 
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evolved to serve as energy-producing organelle with components encoded in their own 
DNA and nuclear DNA (86, 87). Many metabolic intermediates that are formed from 
biochemical reactions such as the tricarboxylic acid (TCA) cycle inside mitochondria 
also play fundamental roles in building essential biological molecules (88). From a 
signaling perspective, mitochondria are important units participating in several cellular 
responses. Notably, mitochondrial apoptosis pathway is initiated by release of 
cytochrome c and other pro-apoptotic molecules from the organelle in the presence of its 
respective stress (89). Additionally, mitochondrial dysfunction can evoke adaptive 
cellular responses, many of which are mediated by transcriptional responses in nucleus, 
suggesting communication between mitochondria and nucleus (90, 91). In the following 
sections, the mitochondria-nucleus communication will be discussed with particular 
emphasis on its potential link to thermogenic gene expression in brown fat. 
 
1.3.1. Mitochondrial retrograde signaling 
The mitochondria-nucleus crosstalk is a pathway of interorganelle communication, 
which is generally termed as mitochondrial retrograde signaling. As suggested by the 
term, information flows from mitochondria to the nucleus, which is contrary to the 
typical anterograde regulation involving transmission of signals from nucleus to 
mitochondria. This retrograde signaling represents diverse adaptive cellular responses 
elicited by various mitochondrial stresses (Figure 1.3). Initially, the retrograde signaling 
was described in the mitochondrial DNA-depleted strain of Saccharomyces cerevisiae (° 
petites). The most prominent in these respiration-defective ° cells is metabolic  
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Figure 1.3. Diverse mitochondrial insults and their outcomes. (Adapted and modified 
from Yun and Finkel, Cell Metab. 2014;19(5):757-66) 
 
remodeling to ensure proper supply of glutamate (92). This is important because the TCA 
cycle cannot operate as a full cycle in a respiration-deficient state and this eventually 
results in depletion of -ketoglutarate, a precursor of glutamate. To overcome the 
metabolically detrimental state, respiration-deficient cells engages peroxisomal 
biogenesis that leads to increases in fatty acid oxidation and glyoxylate cycle activity, 
which can supply TCA cycle intermediates acetyl-CoA and citrate, respectively (92). 
This metabolic reprogramming was also accompanied by supportive transcriptional 
changes; genes encoding transporters for transfer of key metabolites into mitochondria, 
genes encoding TCA cycle enzymes responsible for production of -ketoglutarate and 
genes encoding peroxisomal proteins were up-regulated (92, 93). To withstand an ATP 
15 
 
crisis, glycolytic genes are also up-regulated (94). Similarly, in mammalian cells, 
disruption of oxidative phosphorylation activates PGC-1-driven mitochondrial 
biogenesis to resolve a crisis in cellular energetics (95).  
In addition to mitochondrial respiratory defects, a distinct form of mitochondrial 
stress can induce a corresponding adaptive response. When misfolded proteins are 
accumulated in mitochondria, an ER stress response-like pathway is activated, which is 
also known as the mitochondrial unfolded protein response (UPR
mt
) (96-99). This 
pathway promotes the expression of a set of mitochondrial chaperones and proteases to 
reestablish protein quality control. Well characterized in Caenorhabditis elegans, 
activating transcription factor associated with stress-1 (ATFS-1) plays a crucial role in 
upregulating the respective genes (98, 99). Although paradoxical, this mitochondrial 
stress response appears to yield a beneficial effect. Several lines of evidence suggest that 
activation of the UPR
mt
 is required for an increased lifespan in certain experimental 
conditions in worms (100, 101). In contrast, the mitochondria-driven signal is also known 
to play a critical role in various pathological conditions including cancer, 
neurodegeneration and cardiovascular diseases (102-104), reinforcing the idea that 
mitochondrial retrograde signaling elicits context-dependent and tissue-specific responses.  
 
1.3.2. Genetic manipulation of respiratory capacity and its effect on thermogenic 
gene expression  
Intuitively, it makes sense that in brown fat, a highly specialized tissue for 
thermogenesis, such mitochondria-nucleus communication may be crucial in matching 
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functional and metabolic capacity to genetic programs that influence them. Since 
respiratory capacity is directly correlated with the number of mitochondria, manipulating 
factors controlling mitochondrial biogenesis may be feasible to explore the role of 
mitochondria in the regulation of brown fat-specific thermogenic genes. As summarized 
in Table 1.1, however, deletion of well-characterized drivers of mitochondrial biogenesis 
did not necessarily abrogate the mitochondrial mass in brown fat, implying the existence 
of redundant pathways and/or complementary roles of each regulator (105-111). 
Furthermore, in some models, targeting the same factor did not produce similar effects on 
thermogenic genes, making it challenging to delineate a direct relationship between 
respiratory capacity and the thermogenic gene program per se.  
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The sections below review approaches to directly manipulate mitochondrial 
respiratory capacity and the attendant effects on the thermogenic genes which are 
summarized in Table 1.2. 
 
1.3.2.1. COX7RP (cytochrome c oxidase subunit VIIa polypeptide 2 like)  
Recent work using COX7RP knockout mice provides direct evidence for the role 
of respiratory capacity in the brown fat gene program (112). In this study, COX7RP was 
identified as a novel assembly factor for respiratory chain supercomplexes in 
mitochondria. ETC complexes are known to form supercomplexes, consisting mainly of 
complex I, III and IV (so-called respirasome), which enhances respiratory activity (113). 
With reduced oxygen consumption at a whole-body level, COX7RP KO mice revealed 
hypertrophic and pale brown fat, generally indicative of defective brown fat. More 
importantly, Ucp1 was severely reduced in this dysmorphic brown fat. Microarray 
analysis also showed a downregulation of several brown fat-enriched genes including 
Dio2 and Elovl3. Expression of PGC-1 coactivators was decreased but their downstream 
targets such as Erra, Nrf1, and Tfam were unaltered, implying no significant impact on 
the PGC-1 coactivator network.  All together, this study strongly suggests that respiratory 
capacity dictates a retrograde signaling from mitochondria to the nucleus regulating the 
thermogenic gene program. 
 
1.3.2.2. TFAM (transcription factor A, mitochondrial)
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One approach to genetically manipulate respiratory capacity is to target 
components of the basal transcriptional machinery of mitochondrial DNA (mtDNA). 
Among them is TFAM, a key player in mtDNA transcription and maintenance (114). 
Fabp4-Cre-driven loss of TFAM led to diminished respiratory activity and a drop in 
mtDNA copy number in brown and white fat (115). Paradoxically, in those mice, brown 
fat showed enhanced respiratory capacity as evidenced by increased oxygen consumption, 
fatty acid oxidation, and citrate synthase activity. Although reduced in weight, this brown 
fat had normal expression of brown fat genes. Similarly, brown fat markers were intact in 
brown fat with Adipoq-Cre-driven loss of TFAM, which was accompanied by increased 
citrate synthase activity (116). Therefore, it is likely that the unaltered brown fat gene 
program in TFAM deficient fat is ascribed to a compensatory increase in respiratory 
capacity. Although not decisive, observations from adipose-specific TFAM knockout 
mice imply that whole-cell respiratory capacity is monitored by an innate sensor to 
dictate the thermogenic gene program.    
 
1.3.2.3. CRIF1 (CR6-interacting factor 1) 
CRIF1 is a mitochondrial protein that controls the translation and insertion of 
mitochondrially encoded respiratory subunits into the inner membrane (117). The 
activities of Complexes I, III and IV are abrogated by CRIF1 deficiency in mouse 
embryonic fibroblasts (117).  The severity of impaired respiratory capacity by ablation of 
CRIF1 is evident in brain-specific and cardiac muscle-specific knockout mice in which 
severe neurodegeneration and premature death develop, respectively (117, 118). Adipose-
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specific CRIF1 knockout mice (driven by Fabp4-Cre) show a developmental defect in 
white fat, reduced body weight and post-natal death at week 3 (119). Brown fat in these 
mice is smaller in size, however, histology is unremarkable and UCP1 expression is 
normal. Because mice die by 3 weeks of age, it was not possible to assess the chronic 
effect of respiratory defects in brown fat. Although mice with Adipoq-Cre-driven 
deletion of CRIF1 were viable, data regarding the brown fat genes were not shown (119). 
Even so, these data could suggest that impaired mitochondrial function does not influence 
brown adipocyte development. Future studies will be necessary to address if 
mitochondrial function is critical for the maintenance of the brown fat program. Finally, 
similar to TFAM, the method by which cellular respiration is disrupted may have 
differential effects on mitochondrial signaling and subsequent transcriptional events in 
the nucleus. 
 
1.3.2.4. LSD1 (Lysine-specific demethylase 1) 
LSD1 demethylates mono- and di-methylated lysines (particularly lysine 4 and 9 
of histone H3) via the cofactor flavin adenosine dinucleotide (FAD) (120). Ubiquitously 
expressed, LSD1 is essential for embryogenesis and tissue-specific differentiation (121). 
In the study by Duteil et al, LSD1 was newly identified as a cold-, and 3-adrenergic 
signaling-inducible protein in mouse white fat (122). Ectopic expression of LSD1 further 
revealed that it was sufficient to induce respiratory capacity through nuclear respiratory 
factor 1(NRF1) in white adipose cell lines. In addition, there was an activation of the 
brown fat gene program including Prdm16, Ppargc1a, and Ucp1 in LSD1-overexpressing 
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white adipocytes. LSD1 transgenic mice confirmed these in vitro findings. Interestingly, 
this browning effect was more robust in subcutaneous white fat where beige adipocytes 
reside. However, in brown fat of LSD1 transgenic mice, respiratory activity was 
modestly increased and there were no significant changes in the brown fat markers. These 
data suggest that augmented respiratory capacity may promote browning by stimulating 
beige adipocytes. 
 
1.3.2.5. LRPPRC (Leucine-rich pentatricopeptide repeat containing motif; also 
called LRP130: leucine-rich protein 130kD) 
A potential role of mitochondrial respiratory capacity in the brown fat gene 
program was reported in a study using LRPPRC-deficient brown adipocytes (123). 
LRPPRC was originally identified as a causal protein in a rare neurological and 
metabolic disorder called Leigh Syndrome French Canadian variant (124). Initial studies 
using human fibroblasts identified defects in cytochrome c oxidase deficiency; however, 
later studies using mouse models revealed that LRPPRC affected the expression of all 
mitochondrially encoded subunits of the ETC (13 subunits) (Figure 1.4), which has 
differential effects on respiratory complex activity related to cell type (125-128). 
Especially, our lab has demonstrated that LRPPRC is a strong coactivator for basal 
mitochondrial transcription machinery consisting of POLRMT and TFB2M (126, 129). 
LRPPRC directly regulates respiratory capacity by controlling the availability of 
mitochondrial-encoded ETC subunits, which further affects oxidative metabolism such as 
fatty acid oxidation (126). Since manipulating LRPPRC has no significant impact on  
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Figure 1.4. Mitochondrial-encoded respiratory subunits. The subunits encoded in 
mitochondrial genome are shown below each respiratory complex. 
 
mitochondrial biogenesis (126), specific alteration of mitochondrial respiratory capacity 
in the desired tissue could be achieved by targeting LRPPRC in a tissue-specific manner, 
which makes it a useful tool to study the effects of mitochondrial respiration on diverse 
cellular processes. 
Brown adipocytes with shRNA-driven depletion of LRPPRC were notable for 
impaired oxygen consumption but intact mitochondrial density and PGC-1 coactivators, 
indicating a specific impairment of respiratory capacity without altering mitochondrial 
biogenesis (123). LRPPRC-deficient brown adipocytes had a marked reduction in brown 
fat-selective genes, including Ucp1 and Cidea, suggesting a link between respiratory 
capacity and a basal expression of certain brown fat genes (123).  
While LRRPRC is weakly expressed in the nucleus, recent data show that the 
majority of LRPPRC is localized to mitochondria and regulates mtDNA-encoded 
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transcripts across various species, suggesting that a nuclear role of LRPPRC in the 
regulation of brown fat genes may be modest and that the predominant effect is mediated 
by impaired cellular respiration (126, 130-132). In addition, cAMP-mediated induction of 
Ucp1 was unaffected in LRPPRC-deficient brown adipocytes (123). Given that PGC-1 
is responsible for this cAMP effect, it is less likely that LRPPRC is an essential part of 
PGC-1 coactivator complexes necessary for Ucp1 expression. Furthermore, in human 
fibroblasts, deficiency of LRPPRC did not affect expression of PGC-1 target genes 
(133), implying that signals are generated by impaired cellular respiration rather than 
reduced nuclear expression of LRPPRC. 
 
1.4. Thesis overview   
The goal of my thesis research is to understand the role of mitochondrial 
respiratory capacity in the regulation of thermogenic gene expression in brown fat. Based 
on the previous studies by our lab and others, I have formulated the central hypothesis 
that the status of mitochondrial respiratory capacity dictates the thermogenic gene 
program, which in turn critically determines the metabolic commitment of the tissue 
(Figure 1.5). To test this hypothesis, I investigated two specific aims using LRPPRC as a 
model system. 
 
1.4.1. Specific Aim 1: Characterize the effect of impaired respiratory capacity on the 
thermogenic gene program and determine how the mitochondria signal dictates 
thermogenic gene expression 
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Figure 1.5. The central hypothesis.  Thermogenesis relies on mitochondrial respiration; 
thus brown fat with normal respiratory capacity are ready for thermogenesis and 
thermogenic genes are normally expressed, both of which support thermogenic function 
of brown fat. On the other hand, impaired respiratory capacity, which is an unfavorable 
condition for thermogenesis, activates a retrograde signaling pathway to attenuate 
thermogenic gene expression. Reduced mitochondrial respiration and reduced 
thermogenic gene expression eventually directs brown fat to an energy-storing mode. In 
other words, brown fat coordinates its respiratory capacity with thermogenic gene 
expression. This contributes to determining which metabolic state brown fat adopts. 
 
Recent studies suggest that the actions of mitochondria extend beyond their 
conventional role as generators of heat. There is mounting evidence that impaired 
mitochondrial respiratory capacity is accompanied by attenuated expression of Ucp1. 
This implies a mitochondrial retrograde signaling that negatively influences the 
thermogenic gene program, culminating in a storage phenotype. In this aim, I used 
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genetic (LRPPRC fat-specific knockout) and pharmacological (respiratory inhibitor) 
approaches to model impaired respiratory capacity in mouse brown fat and cultured 
brown adipocytes, respectively. I observed the attenuation of a group of thermogenic and 
oxidative genes. I also identified PPARas the key transcription factor that are 
influenced by the respiratory defect and calcium as the signal that mitochondrial 
respiration uses to control nuclear transcription.   
 
1.4.2. Specific Aim 2: Evaluate if augmented respiratory capacity induces the 
thermogenic gene program in adipose tissue and protects against obesity 
This aim tested a therapeutic aspect of manipulating adipose respiratory capacity 
in the setting of diet-induced obesity. I generated LRPPRC fat-specific transgenic mice 
and observed an induction of the thermogenic genes in inguinal (subcutaneous) white fat. 
In addition, I discovered that such induction was beneficial for fighting obesity and 
diabetes largely through increased whole-body energy expenditure. 
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CHAPTER II 
MITOCHONDRIAL RETROGRADE SIGNALING CONNECTS 
RESPIRATORY CAPACITY TO THERMOGENIC GENE 
EXPRESSION 
 
Summary 
Mitochondrial respiration plays a crucial role in determining the metabolic state 
of brown adipose tissue (BAT), due to its direct roles in thermogenesis, as well as 
through additional mechanisms. Here, we show that respiration-dependent retrograde 
signaling from mitochondria to nucleus contributes to genetic and metabolic 
reprogramming of BAT. In mouse BAT, ablation of LRPPRC (LRP130), a potent 
regulator of mitochondrial transcription and respiratory capacity, triggers down-
regulation of thermogenic genes, promoting a storage phenotype in BAT. This retrograde 
regulation functions by inhibiting the recruitment of PPAR to the regulatory elements of 
thermogenic genes. Chelating cytosolic Ca
2+
 reverses the attenuation of thermogenic 
genes in brown adipocytes with impaired respiratory capacity, while induction of 
cytosolic Ca
2+
 phenocopies the attenuation program, indicating that cytosolic Ca
2+ 
mediates mitochondria-nucleus crosstalk. Our findings suggest that respiratory capacity 
governs thermogenic gene expression and BAT function via mitochondria-nucleus 
communication, which in turn leads to either a thermogenic or storage mode.  
Conversely, augmented respiratory capacity induces thermogenic gene expression 
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in subcutaneous white adipose tissue. Consequently, mice are protected against diet-
induced obesity through increased energy expenditure. These data suggest that 
augmenting respiratory capacity in adipose tissue provides new avenue for fighting 
obesity and diabetes. 
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Introduction 
Brown adipose tissue (BAT) generates heat to combat cold stress (11). When 
activated by cold or -agonists, BAT oxidizes glucose and lipids (in the form of fatty 
acids) to fuel uncoupling protein 1 (UCP1)-mediated uncoupled respiration, which drives 
non-shivering thermogenesis (79). Due to this unique energy-burning property, BAT has 
the potential to mitigate obesity (134, 135). Since functional BAT exists in adult human 
subjects (11) and likewise has the potential to mitigate obesity, there is great interest in 
understanding the molecular and cellular pathways that dictate its development, 
recruitment and maintenance.  
Thermogenesis from BAT relies on abundant mitochondria in the tissue (79). This 
makes BAT capable of higher levels of respiration than any other tissues (136). It is thus 
readily anticipated that the metabolic state of BAT is influenced by mitochondrial 
respiration. Any circumstance where respiratory activity is low leads to reduced substrate 
oxidation, and will drive lipid accumulation in brown adipocytes like white adipocytes 
specialized for storing excess energy as lipids. On the other hand, high respiratory 
activity entails elevated substrate oxidation, thereby resulting in an energy-burning state 
in which stored lipids as well as uptaken glucose and lipids are oxidized. These two 
metabolic fates of BAT are also supported by two distinct gene programs. Lipogenic 
genes are enriched in both white and brown adipocytes, controlling fatty acid synthesis 
and esterification of glycerol with fatty acids. Thermogenic genes are uniquely expressed 
in BAT and oxidative genes are also highly present to enable high rates of fuel oxidation 
and respiration required for thermogenesis.  
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Previous studies have suggested that BAT senses its respiratory capacity and 
coordinates the expression of thermogenic genes to determine which metabolic states 
BAT adopts. Mice deficient for COX7RP, a factor that ensures proper function of 
mitochondrial respiratory complexes, exhibit increased lipid deposition in BAT (112). 
Interestingly, expression of several thermogenic genes including Ucp1, Dio2 and Elovl3 
is concurrently decreased. This suggests that mitochondria with impaired respiratory 
capacity communicate with the nucleus to attenuate expression of certain thermogenic 
genes. A similar mitochondria-nucleus communication has been described in brown 
adipocytes deficient for LRPPRC (123). Lrpprc is the causative gene of the French-
Canadian type of Leigh Syndrome, a rare metabolic and neurological disorder (124). 
LRPPRC is a mitochondrial protein and has been shown to regulate mitochondrial-
encoded electron transport chain (ETC) subunits and thus respiratory capacity by our 
laboratory and others (126, 132, 133, 137). LRPPRC knockdown causes a reduction in 
mitochondrial respiratory capacity and decreased expression of thermogenic genes 
including Ucp1 and Cidea (123). However, gene expression profiling in BAT with 
impaired respiratory capacity is incomplete and the molecular mechanism by which 
mitochondria exert transcriptional control over those nuclear genes remains to be 
addressed.  
In the present study, we explored the role of respiratory capacity in thermogenic 
gene expression by manipulating LRPPRC in an adipose-specific manner and by treating 
brown adipocytes with an inhibitor of mitochondrial respiration. We find that impaired 
respiratory capacity triggers a retrograde signaling pathway that represses thermogenic 
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and oxidative genes, favoring decreased fuel oxidation and energy storage. Furthermore, 
we provide evidence that this information is transmitted via Ca
2+
-mediated mitochondrial 
retrograde signaling, which ultimately controls whether BAT participates in 
thermogenesis or energy storage. Additionally, we tested whether augmenting respiratory 
capacity by force expressing LRPPRC promotes thermogenic gene expression in adipose 
tissue. We show that augmented respiratory capacity activates the thermogenic gene 
program in inguinal (subcutaneous) white adipose tissue (IWAT), which protects mice 
from diet-induced obesity through increased energy expenditure. 
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Materials and Methods 
Animals 
Lrpprc
flox/flox
 mice were generated as previously described (129). To ablate Lrpprc 
in a fat-specific manner, Lrpprc
flox/flox
 mice were crossed to Adipoq-Cre mice. The 
resultant Lrpprc
flox/+
;Adipoq-cre/0 mice were then crossed to Lrp130
flox/flox
 mice to 
produce Lrpprc
flox/flox
;Adipoq-cre/0 mice (termed LRPPRC FKO). Our final breeding 
strategy was to cross Lrpprc
flox/flox
 mice to LRPPRC FKO mice, resulting in 
Lrpprc
flox/flox
:LRPPRC FKO=1:1. Because there was no metabolic or genetic differences 
between WT, flox/flox mice or Adipoq-Cre/0 mice, comparisons between control 
(flox/flox) and Lrpprc
flox/flox
;Adipoq-cre/0 mice were use for this study. Lrpprc
flox/flox
 mice 
and Adipoq-Cre mice are on a C57BL6/J background. 
Mice with ectopic transgenic expression of LRPPRC were generated by 
constructing an inducible floxed LRPPRC cassette. Mouse Lrpprc with Myc and His 
fused at its C-terminus was inserted into the Cre-activable pCAG-CAT-EGFP construct 
(a gift from Dr. Junichi Miyazaki at Osaka University) in place of EGFP cDNA. 
Microinjection into C57BL/6J eggs was performed by UMMS Transgenic animal core 
facility using the linearized construct. Transgenic founders were identified by a 
quantitative PCR and bred to produce offsprings. Mice hemizygous for the transgene 
(Lrpprc
Tg/0
) were crossed to Adipoq-Cre mice to yield WT: Lrpprc
Tg/0
:Adipoq-cre/0: 
Lrpprc
Tg/0
;Adipoq-cre/0 (termed LRPPRC FTg)= 1:1:1:1. For high-fat diet feeding, mice 
were fed a 55% kcal from fat diet (Harlan Teklad TD-93075) for 16 weeks before 
metabolic phenotyping. Mice were maintained in 12-hour light/12-hour dark cycle. In all 
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experiments, LRPPRC FKO and FTg mice had appropriate littermate control mice with 
the same age. All animal experiments were performed in accordance with protocols 
approved by UMMS IACUC (Docket number 2085).  
 
Cold exposure 
Mice were acclimatized at 30 °C for 4 weeks. The mice were then housed 
individually and acutely exposed to cold (4 °C). Rectal temperature was measured hourly 
using a digital thermometer (MicroTherma 2T, Thermoworks) and a rectal probe (RET-3, 
Physitemp) for up to 8 hours. The end point was a 10 °C drop in core temperature 
(approximately 27 °C) and mice were immediately euthanized.  
 
Histology  
For hematoxylin and eosin (H&E) staining, brown adipose tissue was collected, 
washed in ice-cold PBS and fixed in 4% paraformaldehyde with gentle shaking at 4°C 
overnight. Subsequent procedures were performed by UMMS morphology core facility. 
 
Transmission electron microscopy (TEM) 
BAT was dissected and chopped finely in PBS, followed by overnight fixation in 0.1M 
cacodylate buffer (pH 7.2) containing 2.5 M glutaraldehyde. Sample preparation and 
image acquisition were performed by UMMS core electron microscopy facility using FEI 
Tecnai Spirit 12 TEM. 
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Metabolic phenotyping 
Composition of fat and lean mass was measured using 1H-MRS (Echo Medical 
System) and analysis of food/water intake, physical activity and energy expenditure was 
performed by the UMMS Mouse Metabolic Phenotyping Core using metabolic cages 
(TSE Systems). 
 
Glucose and Insulin Tolerance Testing (GTT/ITT) 
Glucose and insulin tolerance testing was performed at 14 weeks of HFD feeding 
as previously described (138). 
 
Reverse transcription-quantitative PCR (RT-qPCR) 
Total RNA was isolated from cell culture using Trizol according to the 
manufacturer instructions (Invitrogen). For mouse adipose tissue, the aqueous phase 
prepared from Trizol extraction was subject to acidic phenol extraction (pH 4.4) to 
remove residual lipid, followed by purification using RNeasy (Qiagen) or GeneJET RNA 
columns (Thermo Scientific). cDNA was synthesized from 0.5-1 μg RNA, using 
MultiScribe reverse transcriptase (Applied Biosystems). Quantitative PCR was 
performed using Fast SYBR Green Master Mix (Applied Biosystems) on a 7500 FAST 
Real-Time PCR system (Applied Biosystems). For a normalization purpose, several 
widely used internal control genes were tested in all experimental groups and the most 
stable one was selected. Relative gene expression was calculated by the comparative CT 
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method. Coefficient of variation for the reference genes was less than 1% across samples. 
Primers are listed in Table. 2.1. 
 
Quantification of mitochondrial DNA (mtDNA) content  
Approximately 5-10 mg of frozen brown fat were lysed in 300 μL tissue lysis 
buffer (50 mM Tris-Cl pH 7.5, 50 mM EDTA pH 8.0, 100 mM NaCl, 1% Triton X-100, 
5 mM DTT and 100 mg/ml proteinase K) at 56 °C for 6 hours. DNA isolation and 
quantitative PCR were performed as previously described (129). 
 
Immunoblotting  
Approximately 10 mg of frozen brown fat or 50 mg of frozen inguinal white fat 
were placed in ice-cold RIPA buffer supplemented with protease inhibitor cocktail 
(Sigma), phosphatase inhibitor cocktail (Sigma) and sodium -glycerophosphate. The 
tissue was then homogenized using a bead mill homogenizer (Qiagen TissueLyzer). The 
lysates were vortexed vigorously for 5 seconds, incubated on ice for 10 minutes and 
cleared by centrifuging at 13200 rpm for 15 minutes at 4 °C. Preparation of lysates from 
cell culture was performed as above without using TissueLyser. Protein concentration 
was determined using a BCA kit (Pierce). Indicated amounts of proteins were separated 
on a polyacrylamide gel and blotted onto a PVDF membrane. The membrane was 
blocked in 5% non-fat milk in TBS-tween, followed by incubation with primary 
antibodies directed against proteins of interest and HRP-conjugated secondary antibodies. 
The protein signals were visualized with Amersham ECL kit (GE Healthcare) or 
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WestPico ECL kit (Thermo Scientific) and digitally recorded using Amersham Imager 
600 (GE Healthcare). The antibodies used are as follows: LRPPRC (produced in-house 
using mice); UCP1 (U6382, Sigma); PPAR (sc-7273, Santa Cruz); COXI (ab14705, 
Abcam); COXVa (ab110262, Abcam); NDUFS3 (ab110246, Abcam); Citrate Synthase 
(GTX110624, GeneTex); VDAC (4866, Cell Signaling); ATP2A2 (sc-8095, Santa Cruz); 
ATP2A3 (sc-81759, Santa Cruz); GAPDH (sc-25778, Santa Cruz). 
 
Lactate measurement  
Lactate levels were measured in homogenates prepared from approximately 5-10 
mg of BAT using Lactate Assay kit II (Biovision). For AA-treated cells, lactate secretion 
was measured in culture medium using the same kit.  
 
Complex activity and citrate synthase activity  
Complex activity and citrate synthase activity were measured in BAT 
homogenates as previously described (129, 139).  
 
Chromatin immunoprecipitation (ChIP)  
Interscapular brown fat was collected, washed with ice-cold PBS and finely 
minced.  Minced tissue was cross-linked in 10 volume of PBS containing 1% 
paraformaldehyde for 10 minutes at room temperature on a rotator. Cross-linking was 
quenched by adding a final concentration of 125 mM glycine. The samples were then 
dounced on ice 10 times, washed twice with ice-cold PBS. Disaggregated tissue was 
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placed in 1ml of RSB buffer (3 mM MgCl2, 10 mM NaCl, 10 mM Tris-Cl pH 7.4, 0.1% 
NP-40 and protease inhibitor cocktail [Sigma]), dounced on ice 30 times, incubated on 
ice 5 minutes and filtered through 100 M cell strainer.  The homogenate was centrifuged 
and the pellet was resuspended in nuclei lysis buffer (1% SDS, 10mM EDTA, 50 mM 
Tris-Cl pH 8.1 and protease inhibitor cocktail). The chromatin was subject to three 
sonication cycles (a cycle of 10 minutes with a duty of 30 seconds on / 30 seconds off) 
using Diagenode Bioruptor. The samples were cleared by centrifugation, diluted in ChIP 
dilution buffer (1 % Triton-X100, 2 mM EDTA, 150 mM NaCl, 20mM Tric-Cl pH 8.0 
and protease inhibitor cocktail) and incubated overnight at 4 °C with 2 g of anti-PPAR 
antibody (sc-7196, Santa Cruz). Immunocomplexes were recovered with protein A/G 
beads (Pierce) and eluted DNA was further purified using the QIAquick gel extraction kit 
(Qiagen). Quantitative real-time PCR was performed using specific primers for the 
indicated gene promoters. The primers are designed based on the previously identified 
PPREs (Ucp1 (140); Cpt1b (141); Pank1 and Pdk4 (142); Fabp4 (143); Lpl (144); Cd36 
(145); Plin1 (146)) and listed in Table. 2.2. 
 
Cell culture  
Primary stromal vascular fraction containing preadipocytes was isolated from 
interscapular depot of P0-P2 newborn swiss webster mice (Taconic Biosciences) as 
previously described (123). Primary brown adipocytes were grown to >90% confluence 
in DMEM (Corning) containing 20% FBS, 20 mM HEPES and 1 mM sodium pyruvate.  
Immortalized brown preadipocytes were grown in the same condition except 10% FBS. 
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For adipocyte differentiation, confluent cells were exposed to DMEM containing  0.5 M 
dexamethasone, 125 M indomethacin, 0.5 mM isobutylmethylxanthine, 20 nM insulin, 
1 nM T3 and 10% FBS for 2 days, after which medium was switched to DMEM 
containing 20 nM insulin, 1 nM T3 and 10% FBS, and replenished every 2 days. On day 
6 post differentiation, cells were treated as indicated. At least three independent 
experiments were performed. 
 
Lentiviral transduction 
ATP2A2 shRNA oligomers were annealed and cloned into pLKO.1-hygro 
lentiviral vector as described in the protocol available from Addgene. 21 bp sense 
sequences for shATP2A2 are as follows: shATP2A2 #1: 5’-
GGCGAGAGTTTGATGAATTAA-3’; shATP2A2 #2: 5’-TGACTCTGCTTTGGATTATAA-3’; 
shScr (negative control, Addgene #1864). To produce lentiviruses, HEK-293T cells were 
transfected with the pLKO.1-hygro construct, psPAX2 and pMD2.G using lipofectamine 
2000 (Invitrogen) according to the manufacturer instructions. Medium was replaced after 
16-20 hours of incubation with the DNA:lipofectamine mixture. At 48 hours post 
transfection, medium was harvested and passed through 0.45 m filter (Thermo 
Scientific). The medium was diluted 2-fold in fresh medium and added to subconfluent 
immortalized brown preadipocytes plated in 12-well plate with 4 g/ml polybrene. After 
overnight incubation, cells were replenished with fresh medium and incubated for 
additional 24-30 hours. Cells were then trypsinized and seeded in 100 mm dish in the 
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presence of 400 g/ml hygromycin, after which medium was replaced every 48 hours. At 
day 5-6 post selection, hygromycin was removed and cells were used for differentiation.     
 
Calcium measurement 
Preadipocytes were plated and differentiated in a 96-well clear bottom black plate 
(Costar). Fully differentiated cells (day 6) were washed with 150 ul HBSS (Gibco 14175-
095) supplemented with 1.8 mM CaCl2, 0.8 mM MgSO4, 1 nM T3 and 20 nM insulin. 
Cells were then loaded with 4 M Fluo 4-AM (Invitrogen) in 100 ul HBSS for 1 hour at 
37 °C (30 °C for ATP2A2-deficient cells), followed by two washes with 150 ul HBSS. 
Fluorescence was measured at 485/520 nm in 100 ul HBSS using a microplate reader 
(POLARstar Omega, BMG LABTECH). Three independent experiments were performed 
and each experiment included biological duplicates. 
 
Statistics  
Statistical analyses were performed using GraphPad Prism 6 (ver. 6.07). The 
statistical tests used were specified in the figure legends. Statistical significance was 
defined as P <0.05. The cutoff for a not-significant (ns) P-value to show the exact 
number is 0.07. 
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Results 
LRPPRC fat-specific knockout (FKO) mice exhibit impaired respiratory capacity in 
BAT 
To examine whether respiratory capacity controls BAT gene expression in vivo, 
we generated fat-specific LRPPRC knockout mice (hereafter, FKO mice) by crossing 
LRPPRC floxed mice with Adiponectin-Cre mice. mRNA and protein levels of LRPPRC 
was reduced by >90% in BAT from FKO mice (Figure 2.1A and C). Compared to WT 
mice (LRPPRC fl/fl), expression of mitochondrial-encoded ETC genes were globally 
reduced and COXI protein levels were also decreased (Figure 2.1B and C). Interestingly, 
several nuclear-encoded subunits were also reduced at both mRNA and protein level 
(Figure 2.1C and D). Abrogated expression of the ETC subunits resulted in impaired 
activities of respiratory complexes (Figure 2.1E). Electron microscopy and image 
analysis revealed that WT mitochondria exhibited tightly packed lamellar cristae whereas 
FKO mitochondria displayed dysmorphic cristae architecture alongside reduced number 
of cristae (Figure 2.1F and G). This is in agreement with the previous observation that 
heart-specific loss of LRPPRC leads to disorganized cristae (128). Deficits in respiratory 
capacity were unlikely due to large changes in mitochondrial biogenesis, since markers of 
mitochondrial mass (VDAC, citrate synthase and mtDNA) were unchanged (Figure 2.1C, 
E and H). Furthermore, lactate levels were increased 1.8-fold in FKO mice (Figure 2.1I), 
consistent with previous studies demonstrating that pharmacological inhibition of the 
ETC causes increased lactate production due to increased glycolysis (147). 
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Figure 2.1. Respiratory capacity is impaired in BAT from LRPPRC fat-specific 
knockout (FKO) mice. (A-B) mRNA levels of Lrpprc (A) and mitochondrial-encoded 
ETC genes (B) in BAT from WT mice (fl/fl) and FKO mice. (C) Immunoblot of 
LRPPRC, COXI, NDUFS3, COXVa, VDAC, citrate synthase (CS) and GAPDH (loading 
control) in BAT. (D) mRNA levels of nuclear-encoded ETC genes in BAT. (E) Complex 
activity in BAT. (F) Transmission electron microscopy (TEM) images of mitochondria in 
BAT (16,500X). (G) Number of cristae per m2 of mitochondrion. 6-10 fields per mouse 
were analyzed (n=3; total 174 mitochondria for fl/fl and 120 for FKO). (H) mitochondrial 
DNA (mtDNA) content in BAT. (I) Lactate levels in BAT. (A-E, H): 11-12 week-old 
male, n=3-5. (F,G): 14 week-old male, n=3. Data are mean ± SEM. *P < 0.05, **P < 
0.01, ***P < 0.001, one-tailed (I) and two-tailed unpaired Student’s t-test (A-B, D-E, G-
H). 
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Impaired respiratory capacity attenuates thermogenic gene expression 
Having established a model of deficient respiratory capacity in BAT, we assessed 
BAT function and gene expression. On gross examination, BAT from FKO mice housed 
at room temperature (22 °C at our facility) was pale and enlarged (Figure 2.2A, upper 
panel). Increased lipid deposition with unilocular droplets was apparent in histological 
sections, an appearance associated with reduced respiratory activity (Figure 2.2A, lower 
panel). Although Ucp1 mRNA levels were decreased, we observed that UCP1 protein 
was stabilized in FKO mice housed at room temperature (Figure 2.2B and C). 22 °C is a 
mild cold stressor to mice and such stabilization of UCP1 protein in cooler environments 
has been reported (148). Upon acute cold exposure, these mice were not cold sensitive in 
spite of impaired respiratory capacity (Figure 2.2D). Although not formally assessed, 
augmented shivering thermogenesis due to housing under mild cold stress may 
compensate for UCP1-mediated non-shivering thermogenesis, enabling effective defense 
against cold. Cold also stimulates -adrenergic signaling (134). Since -adrenergic 
signaling is a key regulator of both thermogenic and respiratory programs (149, 150), we 
sought to determine whether impaired respiratory capacity per se affects BAT function 
and gene expression under circumstances devoid of -adrenergic stimulation. To do so, 
mice were acclimated at thermoneutrality (30 °C) for 4 weeks, a timeframe that is 
sufficient to offset the impacts of thermal stress. Even at thermoneutrality, FKO mice 
maintained larger lipid droplets in BAT (Figure 2.3A). Like FKO mice housed at room 
temperature, thermoneutral-acclimated FKO mice displayed robust depletion of LRPPRC 
and severe reduction in levels of COXI and nuclear-encoded respiratory subunits 
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Figure 2.2. Impaired respiratory capacity attenuates thermogenic and oxidative 
gene expression in BAT from LRPPRC FKO mice living at 22 °C. (A) Representative 
images (upper) and H&E staining (lower) of BAT. (B) mRNA levels of thermogenic 
genes in BAT. (C) Immunoblot of PPAR, UCP1 and GAPDH (loading control) in BAT. 
(D) Core temperature of control and LRPPRC FKO mice during acute cold exposure at 
4 °C. (E-G) mRNA levels of FAO genes (E), adipogenic/lipogenic gene (F), and 
mitochondrial biogenesis genes (G) in BAT. (A-D): 9 week-old male mice, n=3-5. Data 
are mean ± SEM. *P<0.05, **P<0.01, ***P<0.001, two-tailed unpaired Student’s t-test 
(B,E-G). 
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while VDAC was unchanged and CS was slightly reduced (Figure 2.3B). In these mice, 
expression of thermogenic genes was severely decreased (Figure 2.3C). Notably, both 
Ucp1 mRNA and protein levels were severely reduced (Figure 2.3C and D), and mice 
were exquisitely sensitive to cold stress (Figure 2.3E).  
We next assessed expression of genes that regulate fatty acid oxidation (FAO), 
adipogenesis, lipogenesis and mitochondrial biogenesis. Interestingly, FAO genes were 
globally reduced (Figure 2.3F). Alongside decreased nuclear-encoded ETC genes, down-
regulation of the FAO genes may favor transitioning of BAT into an energy-storing mode. 
In contrast, Pparg, a master regulator of adipogenesis, and its target lipogenic genes were 
unaltered or upregulated (Figure 2.3G). Ppargc1b and Erra (Esrra) mRNA levels were 
reduced but not Ppargc1a mRNA (Figure 2.3H). Although these genes are involved in 
mitochondrial biogenesis, as stated earlier, markers of mitochondrial mass were 
unchanged, suggesting alterations in various gene programs were not simply the result of 
reduced mitochondrial biogenesis. Mice housed at room temperature showed almost 
identical expression patterns of the aforementioned genes (Figure 2.2B and E-G), 
suggesting that mitochondrial retrograde signaling acts independent of -adrenergic 
signaling. Furthermore, in support of normal -adrenergic signaling in FKO mice living 
at thermoneutrality, the relative fold change for induction of Ppargc1a and Ucp1 was 
comparable to control mice, following a cold stress (Figure 2.4A and B). If some brown 
adipocytes still contained residual LRPPRC, possibly due to inefficient recombination, 
one would predict a normal fold change of gene induction, following cold exposure. To 
exclude this possibility, we measured phosphorylated PKA, which is activated by 
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Figure 2.3. Impaired respiratory capacity attenuates thermogenic and oxidative 
gene expression in BAT from LRPPRC FKO mice living at 30 °C. (A) H&E staining 
of BAT. (B) Immunoblot of LRPPRC, COXI, NDUFS3, COXVa, CS and VDAC in 
BAT. (C) mRNA levels of thermogenic genes in BAT. (D) Immunoblot of UCP1 and 
GAPDH (loading control) in BAT. (E) Core temperature of control and LRPPRC FKO 
mice during acute cold exposure at 4 °C. (F-H) mRNA levels of FAO genes (F), 
adipogenic/lipogenic genes (G) and mitochondrial biogenesis genes (H) in BAT. 12-14 
week-old male were used, n=3-4. Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 
0.001, two-tailed unpaired Student’s t-test (C, E-H). 
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Figure 2.4. -adrenergic signaling is intact in BAT from LRPPRC FKO mice. (A) 
mRNA levels of cold-responsive genes in BAT of thermoneutral-acclimated (30 °C) or 
cold-exposed (4 °C) mice. (B) Table showing fold change for 30 °C vs. 4 °C for the 
genes from (A). (C) Immunoblot of phosphorylated PKA (pPKA Thr197), total PKA and 
GAPDH (loading control). (D) Quantification of pPKA and total PKA relative to 
GAPDH. (a): 12-14 week-old male, n=3-5. (C-D): 12 week-old male mice, n=3-5. Data 
are mean ± SEM. *P<0.05, **P<0.01, ***P<0.001, two-tailed unpaired Student’s t-test 
(A,D). 
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-adrenergic signaling. In BAT, pPKA was unchanged in FKO mice living at room 
temperature (Figure 2.4C and D), further supporting that the -adrenergic signaling 
pathway was not altered.  
In summary, these data indicate that impaired respiratory capacity triggers a 
retrograde signaling pathway that represses thermogenic and oxidative genes, favoring 
decreased fuel oxidation and thus energy storage. This may explain why lipid 
accumulation was increased in LRPPRC-deficient BAT.   
 
Impaired respiratory capacity interferes with the recruitment of PPAR to 
thermogenic gene promoters 
We were interested in the transcriptional basis by which deficits in respiratory 
capacity affects thermogenic gene expression. PPAR governs many aspects of brown fat 
development and maintenance (151, 152). Protein levels of PPAR and coactivators 
including SRC1 and PGC-1, however, were unchanged in LRPPRC FKO mice (Figure 
2.5A). Even so, PPAR has been shown to exhibit promoter specificity under certain 
metabolic conditions (153). We, therefore, queried whether or not the recruitment of 
PPAR to various transcriptional regulatory units was altered using ChIP assays (Figure 
2.5B). As shown in Figure 2.5C, the recruitment of PPAR to the enhancer region of 
Ucp1 and the promoters of other thermogenic genes was reduced. Because PPAR is 
required for the expression of these genes (142, 154), reduced recruitment to these 
regulatory regions might explain their reduced transcription. Interestingly, recruitment of  
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Figure 2.5. Impaired respiratory capacity influences the recruitment of PPAR in a 
promoter-specific manner. (A) Immunoblot of PPAR, SRC1, PGC-1 and GAPDH 
(loading control) in BAT. (B) Schematic diagram depicting the positions of primers used 
for ChIP and the positions/sequences of PPREs of the genes assessed by ChIP assays. 
Filled bar: previously identified PPRE; Open bar: putative PPRE. The arrows indicate the 
positions of primers. (C-D) PPARChIP assay of thermogenic and oxidative gene 
enhancer/promoters (C) and lipogenic gene promoters (D) in BAT. 12-14 week-old male 
at 30 °C. (C-D): n=4-5. Data are mean ± SEM. *P < 0.05, **P < 0.01, two-tailed 
unpaired Student’s t-test (C,D).  
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PPAR to the promoters of lipogenic genes was unchanged with some minimally affected 
(Figure 2.5D), a finding consistent with intact lipogenic gene expression in LRPPRC 
FKO mice (Figure 2.3G). These data suggest that mitochondrial retrograde signaling 
influences promoter specific recruitment of PPAR, a metabolic switch that governs 
whether or not BAT adopts a thermogenic or storage phenotype. 
 
Cytosolic calcium may mediate retrograde signals from mitochondria to nucleus 
Next, we tested whether pharmacological inhibition of respiratory complex can 
recapitulate the findings from genetic model of impaired respiratory capacity (LRPPRC 
FKO mice). Since electrons entered from complexes I and II converge at complex III, 
inhibiting complex III will block the entire electron transit, which impairs respiratory 
capacity. Thus we treated primary cultured brown adipocytes with antimycin A (AA), an 
inhibitor of complex III. As in BAT from LRPPRC FKO mice, lactate levels were 
increased in AA-treated brown adipocytes (Figure 2.6A). Notably, AA treatment resulted 
in the reduced expression of several thermogenic genes such as Ucp1 and Cidea and 
minimally affected adipogenic and lipogenic genes (Figure 2.6.B and C). UCP1 protein 
was also reduced whereas PPAR and its coactivators SRC1 and PGC-1 were unaltered 
(Figure 2.6D). Overall, inhibiting ETC in cell culture recapitulates the findings from 
LRPPRC FKO mice, providing an in vitro model to study downstream signaling pathway. 
These data also suggest that the effects of impaired respiratory capacity on thermogenic 
gene expression are cell autonomous. 
Several studies have shown that ETC dysfunction leads to increased cytosolic  
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Figure 2.6. Pharmacological inhibition of respiratory complex mimics LRPPRC 
ablation in cultured brown adipocytes. (A) Representative image of acidic media 
(upper) and lactate production (lower) in primary brown adipocytes treated with 10 nM 
AA for 18 hr. (B-C) Thermogenic gene expression (B) and adipogenic/lipogenic gene 
expression (C) in cells from (A). (D) Immunoblot of UCP1, PPAR, SRC1, PGC-1 and 
GAPDH (loading control). Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, 
two-tailed unpaired Student’s t-test (A-C). 
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Ca
2+
 levels (155-157). These studies demonstrated that Cathepsin L (Ctsl) was induced in 
a Ca
2+
-dependent manner. First, as an indirect measure of altered cytosolic Ca
2+
 levels, 
we quantified Ctsl mRNA in BAT from LRPPRC FKO mice and AA-treated brown 
adipocytes. Ctsl gene expression was induced in FKO mice housed at 22 °C and 30 °C 
and AA-treated cells, indicating elevated levels of cytosolic Ca
2+
 (Figure 2.7A and B). 
Next, we quantified steady-state levels of cytosolic Ca
2+
, and observed a 20% increase in 
AA-treated brown adipocytes (Figure 2.7C). We then examined if reduction of free 
cytosolic Ca
2+
 levels can rescue AA-mediated repression of thermogenic genes using 
BAPTA-AM, a cell-permeable Ca
2+
 chelator. BAPTA partially rescued AA-mediated 
decreases in thermogenic genes but had no effect on lipogenic genes (Figure 2.7D and E). 
BAPTA was also able to reverse AA-dependent induction of Ctsl (Figure 2.7D), 
indicating that BAPTA effectively blocked Ca
2+
-dependent alterations in gene expression. 
In summary, these data support a model in which Ca
2+
 serves as a signaling mediator for 
the attenuation of thermogenic genes under impaired respiratory capacity.   
Finally, we tested whether increasing cytosolic Ca
2+
 mimics the effects of 
impaired respiratory capacity by silencing sarco/endoplasmic reticulum (SR/ER) Ca
2+
-
ATPase (SERCA) in brown adipocytes. Since SERCA transports Ca
2+
 from cytosol into 
SR/ER at the expense of ATP, cytosolic Ca
2+
 is expected to be increased in SERCA-
deficient cells. Although three paralogous genes encode SERCA (Atp2a1, Atp2a2 and 
Atp2a3), mouse brown adipocytes only express Atp2a2 and Atp2a3 with the latter being 
induced upon differentiation (data not shown). Immunoblot analysis confirmed protein 
expression of ATP2A2 (SERCA2) in cultured brown adipocytes but ATP2A3 (SERCA3)  
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Figure 2.7. Cytosolic Ca
2+
 serves as a signaling mediator between BAT 
mitochondria and nucleus. (A-B) mRNA levels of Ctsl in BAT (A) and primary brown 
adipocytes (B). (C) Measurement of cytosolic Ca
2+ 
in immortalized primary brown 
adipocytes using a Ca
2+
-specific fluorescent indicator, Fluo4-AM. (D-E) mRNA levels of 
thermogenic genes (D) and adipogenic/lipogenic genes (E) in immortalized primary 
brown adipocytes co-treated with AA and BAPTA. 40 M BAPTA-AM was loaded into 
cells for 1 hr, followed by treatment with 20 nM AA for 18 hr. (F) Immunoblot of 
ATP2A2, ATP2A3, UCP1 and GAPDH (loading control). Short: short exposure; Long: 
long exposure; Lg: large. Heart was used as a positive control for ATP2A2 and ATP2A3. 
Lg. intestine was used as a positive control for ATP2A3. (G) Oil red O staining of 
immortalized primary brown adipocytes stably transduced with ATP2A2 shRNA and 
immunoblot of ATP2A2, UCP1, PPAR and GAPDH (loading control). (H) 
Measurement of cytosolic Ca
2+
 in immortalized primary brown adipocytes stably 
expressing shATP2A2. (I-L) mRNA levels of thermogenic genes (I), 
adipogenic/lipogenic genes (J), mitochondrial biogenesis genes (K) and mitochondrial-
encoded ETC genes (L). (A): n=3-5.  Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P 
< 0.001, two-tailed unpaired Student’s t-test (A-E, H-L). 
54 
 
was undetectable with our immunoblotting methods in the same cells (Figure 2.7F). Even 
though low levels of ATP2A3 protein are expressed, ATP2A3 has unusually low Ca
2+
 
affinity, rendering it essentially inactive at normal intracellular Ca
2+
 concentration 
(≤0.1M) (158). Therefore, we chose to silence a single isoform: ATP2A2. Two different 
sequences of ATP2A2 shRNA yielded moderate to severe silencing (Figure 2.7G). Oil 
red O staining and unaltered PPAR protein indicated no apparent effect of ATP2A2 
knockdown on differentiation (Figure 2.7G). Cytosolic Ca
2+
 was increased in cells with 
severe knockdown but not with modest knockdown (Figure 2.7H); we speculate that any 
change that may be caused by moderate knockdown of ATP2A2 appears to be outside the 
detection range of the method. Nonetheless, Ucp1 mRNA and protein were reduced in 
proportion to the extent of ATP2A2 knockdown (Figure 2.7G and I). Other thermogenic 
genes were also similarly repressed (Figure 2.7I) whereas lipogenic genes were 
unaffected with some slightly induced (Figure 2.7J) and genes regulating mitochondrial 
biogenesis exhibited minimal changes (Figure 2.7K). Finally, Lrpprc and mitochondrial-
encoded respiratory genes were unaltered, indicating that SERCA knockdown affects 
Ca
2+
 trafficking through a distinct mechanism (Figure 2.7K and L). Together, these data 
support that cytosolic Ca
2+
 may be a second messenger for the mitochondrial retrograde 
signaling in brown adipocytes. 
 
Augmented respiratory capacity induces the thermogenic gene program in 
subcutaneous adipose tissue 
Data from FKO mice motivated the hypothesis that augmented respiratory  
55 
 
 
 
Figure 2.8. Lrpprc and mitochondrially encoded genes are induced in IWAT of 
LRPPRC fat-specific transgenic (FTg) mice. (A) Schematic diagram of a construct 
allowing fat-specific expression of LRPPRC. (B) KpnI/PmeI-digested 8.1kb transgene 
construct used for microinjection. (C) Immunoblot of LRPPRC, Myc-tag and -actin 
(loading control) in HEK293T cells transfected with the construct and Cre recombinase 
(Cre)-carrying plasmid. (D) mRNA levels of Lrpprc in inguinal white adipose tissue 
(IWAT) from LRPPRC FTg mice. (E) mRNA levels of mitochondrial-encoded ETC 
genes in IWAT. (E) Immunoblot of LRPPRC, Myc-tag and UCP1 in IWAT. (F) Gene 
expression in IWAT. 12-14 week-old male mice at 22 °C, n=3-4. Data are mean ± SEM. 
*P<0.05, **P<0.01, two-tailed unpaired Student’s t test (D,E,G). CAG: chicken -actin 
promoter; CAT: chloramphenicol acetyltransferase; mLRPPRC: mouse LRPPRC. 
56 
 
capacity activates the thermogenic gene program in adipose tissue. To test this hypothesis, 
we generated mice with ectopic expression of Myc-tagged LRPPRC in adipose tissue 
(LRPPRC FTg) (Figure 2.8A and B). The transgene encoding LRPPRC was activated 
only in the presence of Cre recombinase (Figure 2.8C). In BAT, the transgene was not 
sufficient to influence total endogenous Lrpprc gene expression presumably because 
LRPPRC levels are very high. In IWAT, however, ectopic expression of LRPPRC 
increased LRPPRC protein and mRNA as wells as its target genes (Figure 2.8D-F). We 
suspect that the modest expression of LRPPRC may be due to dilutional effects of the 
presence of non-adipocytic cells. Ucp1 mRNA and protein were induced and the levels of 
several BAT-specific genes including Cidea and Dio2 were also increased (Figures 2.8F 
and G). Overall, the collective data suggest augmenting respiratory capacity is sufficient 
for ‘browning’ of subcutaneous white adipose tissue. 
 
The browning of subcutaneous adipose tissue protects against diet-induced obesity 
in LRPPRC FTg mice  
Browning of IWAT enhances energy expenditure, leading to metabolic improvements in 
mice fed a high fat diet (HFD) (122, 159). We tested whether LRPPRC FTg mice could 
benefit from browning of IWAT under metabolic stress. To avoid any confounding 
effects of thermal stress on the whole body metabolism at 22 °C, animals were 
acclimated to thermoneutral conditions for 4 weeks upon weaning, followed by 16 weeks 
of HFD feeding. We first assessed mice carrying the transgene (Flox/0) alone after HFD 
feeding to rule out any unintended impacts from insertion of the transgene. Flox/0  
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Figure 2.9. Mice with the LRPPRC transgene are metabolically similar to WT 
littermates upon HFD feeding. (A) Body weight, (B) Body composition, (C) Food and 
water intake, (D) Whole body oxygen consumption (VO2), (E) Area under curve of (D), 
(F) Physical activity, and (G) Glucose and (H) Insulin tolerance test (GTT/ITT) in 
wildtype (WT) littermates and transgene-carrying mice (Flox/0) fed a HFD. (A-H): n=5-7. 
Data are mean ± SEM. Multiple t tests using the Bonferroni correction (A); Two-tailed 
unpaired (B,C,E,F) Student’s t test; two-way ANOVA (D,G,H). 
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mice were similar to WT littermates in terms of their body weight, fat/lean mass and food 
intake (Figure 2.9A-C). In addition, oxygen consumption and physical activity did not 
differ significantly between WT and Flox/0 mice (Figure 2.9D-F). Finally, Flox/0 mice 
were only slightly more insulin-resistant than WT mice (Figure 2.9G and H). Overall, we 
concluded that the LRPPRC transgene per se had minimal effect on whole body 
metabolism. We next measured the same metabolic parameters in HFD-fed LRPPRC FTg 
mice. FTg mice gained less weight (~15%) than their littermate controls (Adipo-cre/0) 
(Figure 2.10A), consistent with a reduction in fat mass observed in these animals (Figure 
2.10B). Given no significant difference in food intake (Figure 2.10C), it is likely that 
alterations in energy expenditure explain the lower fat accumulation in FTg mice. Indeed, 
we observed that oxygen consumption was increased in these mice (Figure 2.10D and E). 
Although diurnal physical activity was similar, FTg mice showed a tendency for 
increased nocturnal physical activity, which may be due to their lower body weight and 
may contribute to higher energy expenditure during the night cycle (Figure 2.10F). In 
addition, as reported by others, reduced body weight and increased energy expenditure 
was associated with improved whole-body insulin sensitivity in FTg mice (Figure 2.10G 
and H). Notably, these mice exhibited brown-like adipocytes bearing multilocular lipid 
droplets in IWAT, while similar cells were rarely seen in IWAT from control mice 
(Figure 2.10I). Collectively, these data demonstrate that browning by augmented 
respiratory capacity in adipose tissue promotes resistance to diet-induced obesity 
primarily via increased energy expenditure. 
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Figure 2.10. LRPPRC FTg mice exhibit improved metabolic phenotypes in diet-
induced obesity. (A) Body weight,  (B) Body composition, (C) Food and water intake, 
(D) Whole body oxygen consumption (VO2), (E) Area under curve (AUC) of (D), (F) 
Physical activity, (G) Glucose and (H) Insulin tolerance test (GTT/ITT), and (I) 
Representative H&E staining images of IWAT in Adipo-cre/0 (control) and LRPPRC 
FTg mice fed a high-fat diet (HFD). Scale bar: 100m (100x); 50m (400x). (A-I): n=5-6. 
Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, multiple t tests using the 
Bonferroni correction (A); one-tailed unpaired (E) and two-tailed unpaired (B,C,F) 
Student’s t test; two-way ANOVA (D,G,H). 
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Discussion 
In this study, we tested whether reducing respiratory capacity in mouse BAT 
affects thermogenic gene expression and BAT function. We modeled impaired 
respiratory capacity by ablating LRPPRC in an adipose-specific manner. Impaired 
respiratory capacity activated retrograde signaling pathway to attenuate thermogenic and 
oxidative gene expression. The transcriptional basis for this repression was the reduced 
recruitment of PPAR to the promoters of those genes. Using an inhibitor of respiratory 
complex and shRNAs against SERCA pump in cultured brown adipocytes, and 
conversely the chelation of Ca
2+
 under respiration-impaired conditions, we also showed 
that Ca
2+
 mediates the crosstalk between mitochondria and nucleus. Conversely, 
augmenting respiratory capacity in mouse IWAT was sufficient to increase thermogenic 
gene expression. Overall, our work illustrates an adaptive coordination of respiratory 
capacity with the expression of thermogenic genes. 
Mitochondrial retrograde signaling is triggered by various mitochondrial stresses 
(90, 91, 103). This signaling pathway affects nuclear gene expression, resulting in a 
multitude of cellular adaptive responses (90, 91, 103). Our data highlight an adaptive 
response of brown adipocytes to impaired respiratory capacity, which is an unfavorable 
condition for thermogenesis. In contrast, adipose-specific loss of TFAM, an activator of 
mitochondrial transcription and positive regulator of mtDNA replication, had no such 
defects in BAT(115, 116). Despite the reduced expression of mitochondrial-encoded ETC 
genes, however, oxygen consumption, FAO, and citrate synthase activity were 
paradoxically increased in TFAM-deficient BAT(115, 116), which confounds 
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interpretation. Importantly, the phenotypic similarities between LRPPRC ablation and 
pharmacological inhibition of respiratory complex exclude pleiotropic effects of 
LRPPRC loss. Moreover, impaired respiratory capacity was associated with remodeling 
of oxidative program in BAT. In LRPPRC FKO mice, gene programs involved in 
mitochondrial respiration (nuclear-encoded) and fatty acid oxidation were impaired. 
Some of the changes might be explained by reduced expression of Ppargc1b and Erra 
(Esrra), both of which govern mitochondrial biogenesis and fatty acid oxidation and 
(150). It is noteworthy that LRPPRC depletion in hepatocytes had no overt effect on the 
oxidative gene program (160). This differential gene regulation suggests tissue specificity 
of mitochondrial retrograde signaling. Attenuated expression of genes involved in fatty 
acid oxidation was not simply due to decreased mitochondrial content. Interestingly, 
impaired respiratory capacity in BAT was not associated with a compensatory increase in 
mitochondrial content. This is in contrast to inhibition of oxidative phosphorylation 
(OXPHOS) in skeletal muscle where induction of PGC-1 coactivators promotes 
mitochondrial biogenesis to presumably compensate for OXPHOS deficits (95). This 
dichotomy is interesting as it indicates the status of respiratory capacity in BAT globally 
determines adipocyte function: storage versus heat dissipation. With normal respiratory 
capacity, BAT is committed to function as a thermogenic organ and thermogenic and 
oxidative gene expression is maintained. However, upon impaired respiratory capacity, a 
condition unfavorable for thermogenesis, thermogenic and oxidative gene expression is 
suppressed. Concurrently, glycolysis is increased, which can supplement ATP and 
enhance de novo lipogenesis (161). These mechanisms converge to reprogram BAT into 
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a storage mode.  
While we have shown that reduced recruitment of PPAR to the promoters of 
thermogenic genes may be responsible for their attenuated expression, precisely how 
PPAR is dislodged from those promoters remains unknown. A coactivator complex 
consisting of PGC-1, SRC-1/3 and other general coactivators is necessary for PPAR-
dependent thermogenic gene expression but is dispensable for expression of lipogenic 
genes (36, 162). Based on our findings of attenuated (coactivator-dependent) thermogenic 
gene expression but intact (coactivator-independent) lipogenic gene expression, disrupted 
coactivator complex may be a potential mechanism. More importantly, SRC-1 and SRC-
3 are jointly required for recruitment of PPAR to a PPRE site on the Ucp1 enhancer in 
BAT but not to lipogenic gene promoters (162). One possibility is that impaired 
respiratory capacity interferes with the function of SRC family as a PPAR coactivator, 
leading to diminished docking of PPAR on the thermogenic promoters. In addition, 
given a model in which binding of PGC-1 to PPAR promotes recruitment of SRC-1 
and CBP/p300 (163), abrogation of physical interaction between PPAR and PGC-1 
could indirectly hinder PPAR docking by sequestering SRC-1 and possibly SRC-3 from 
PPAR coactivator complexes. 
We provide evidence of cytosolic Ca
2+
 as a signal that may mediate mitochondria-
nucleus crosstalk triggered by impaired respiratory capacity in BAT. It has been reported 
that cytosolic Ca
2+
 was increased by certain mitochondrial stresses including depletion of 
mtDNA and inhibition of the respiratory chain in various cell types, which ultimately 
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affected nuclear gene expression (102, 155, 157, 164). In brown adipocytes treated with 
an inhibitor of respiratory complex, increased cytosolic Ca
2+
 was responsible for 
repressed thermogenic genes. To our knowledge, this is a first report describing Ca
2+
-
mediated mitochondrial retrograde signaling in BAT. In contrast, Ca
2+
 is also known to 
positively regulate BAT thermogenesis. 3-adrenergic stimulation of brown adipocytes 
led to a rise in intracellular Ca
2+
 evoked from mitochondria, ER and entry across plasma 
membrane (165). It has been suggested that Ca
2+
 influx mediated by TRPV2, a Ca
2+
-
permeable non-selective cation channel, was required for isoproterenol-induced 
expression of Ppargc1a and Ucp1 in brown adipocytes (166). Moreover, activation of 
TRPM8, a cold-sensing non-selective cation channel, induced UCP1 expression through 
Ca
2+
-mediated PKA phosphorylation in brown adipocytes (167). This discrepancy 
suggests that mitochondrial retrograde signaling involves a Ca
2+
 signaling pathway that is 
distinct from the one in stimulated brown adipocytes. Although unclear at present, 
investigating how Ca
2+
 influences PPAR and possibly its coactivator complex may help 
elucidate the distinct mechanism, which could prove of therapeutic utility. Defective 
respiratory chain function is associated with deranged mitochondrial Ca
2+
 handling (168, 
169). We speculate that impaired respiratory capacity may impair Ca
2+
 buffering by 
mitochondria, leading to increased cytosolic Ca
2+
. 
Interestingly, our gain-of-function model (LRPPRC FTg) suggests that 
augmented respiratory capacity serves as a transcriptional trigger to promote a BAT-like 
gene signature in certain WAT.  The trigger is functional in IWAT, the only depot in 
which LRPPRC was overexpressed. This may be due to limitations in our transgenic 
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approach that involves random insertion. Indeed, it has been shown that retrovirally 
expressed human LRPPRC successfully increased thermogenic genes including Ucp1, 
Cidea and Dio2 in classic white adipose cell line 3T3-F442A (123). We also do not 
exclude the occurrence of brown-like cells in other white adipose depots such as 
mesenteric depot in LRPPRC FTg mice. It would be interesting to determine whether 
increasing respiratory capacity is a universal mechanism to activate the thermogenic gene 
program in WAT. Under thermoneutral conditions, these FTg mice displayed resistance 
to diet-induced obesity and improved insulin sensitivity as whole-body energy 
expenditure was significantly increased. As stated in the above, we do not exclude a 
possibility that other depots such as mesenteric depot can undergo browning and 
contribute to the metabolic improvements in FTg mice. The limited weight gain could 
potentially affect energy expenditure by altering physical activity. Further analyses are 
needed to determine what portions of increased energy expenditure in FTg mice derive 
from the browning of IWAT. Supporting our data, it has been documented that browning 
of IWAT resulted in similar metabolic improvements in HFD-fed mice via increased 
energy expenditure (122, 159). Importantly, unlike these studies, our work was 
performed at thermoneutrality. Several lines of evidence have demonstrated that housing 
temperature may have confounding impacts on modeling of metabolic diseases in rodents 
(134, 170). Given that humans live predominantly under thermoneutral conditions, our 
work indicate that ‘browning’ of white adipose tissue may be a physiologically plausible 
strategy to fight obesity and diabetes in humans. 
In summary, our study demonstrates that BAT coordinates its respiratory status 
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with the expression of thermogenic and oxidative genes through retrograde signaling to 
determine its metabolic commitment. When respiratory capacity is impaired, BAT adopts 
a storage phenotype by turning off thermogenic genes and down-regulating genes 
involved in fuel oxidation. Furthermore, functioning as a transcriptional trigger, 
augmented respiratory capacity induces thermogenic gene expression in IWAT, which 
increases energy expenditure and protects mice from diet-induced obesity. Our work may 
provide the important framework for future research on mitochondrial control of 
thermogenic gene pathway and energy dissipation. 
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Table 2.1. Mouse primers used for RT-qPCR 
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Table 2.2. Mouse primers used for ChIP assays 
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CHAPTER III 
PERSPECTIVES AND FUTURE DIRECTIONS 
 
3.1. Brown fat-specific mitochondrial retrograde signaling  
Each cell type is designed to perform a highly specialized function that is 
primarily governed by their unique transcriptomes. This cell-type or tissue specificity is 
also reflected in mitochondrial retrograde signaling as manifested by different 
transcriptomic changes and various outcomes in distinct cell types (102, 103, 156). The 
differential effects of LRPPRC deficiency on oxidative genes in hepatocytes and brown 
adipocytes could be explained by the cell type differences. Furthermore, given the 
complex nature of mitochondrial retrograde signaling, responses elicited by 
mitochondrial respiratory defect could be differential depending on the approaches used. 
Although we have seen almost identical changes in key thermogenic genes such as Ucp1 
in brown fat lacking LRPPRC or COX7RP and AA-treated brown adipocytes, it is 
possible that each method differently alters gene expression. Importantly, in order to 
obtain a better understanding of brown fat-specific mitochondrial retrograde signaling, 
whole-transcriptome analysis is critical. Microarray or RNA-seq will be a starting point 
toward this goal. By comparing the data from three models including LRPPRC, COX7RP 
and AA, commonly altered genes can be identified. Then, bioinformatical approaches 
may be able to reveal what functional classes of genes are affected, providing a clue to 
the nature of brown fat-specific mitochondrial retrograde signaling.  
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Mitochondrial retrograde signaling can affect the activities and abundance of 
numerous transcription factors and co-regulators (171). DNA motif analysis may be 
useful to determine a list of candidate transcriptional factors that mediate transcriptomic 
changes provoked by mitochondrial retrograde signaling. Aligning the regulatory 
elements of the genes identified from the comparative transcriptome analysis will allow 
us to profile transcription factor binding sites shared by the genes within each functional 
group. The high-scoring DNA motifs would indicate their relevant transcription factor as 
strong candidates.  
 
3.2. Mitochondrial respiration and calcium 
Mitochondria are important buffers of intracellular Ca
2+ 
(172). To be accumulated 
into mitochondria, Ca
2+
 should pass through their outer and inner membranes. Cations 
such as Ca
2+
 can freely diffuse across the outer mitochondrial membrane (OMM) but not 
the inner mitochondrial membrane (IMM) (172). The fact that Ca
2+
 can be accumulated 
into the mitochondrial matrix (173, 174) motivated a search for transporters responsible 
for mitochondrial Ca
2+
 uptake, and mitochondrial calcium uniporter (MCU) was 
identified (175-178). MCU is highly Ca
2+
-specific but has low Ca
2+
 affinity (179). 
Moreover, Ca
2+
 efflux pathways across the IMM can act against MCU (172). Due to 
these drawbacks, additional components are obligatory for effective and rapid 
accumulation of Ca
2+
 into the mitochondrial matrix. VDAC promotes Ca
2+
 transfer across 
the OMM, resulting in locally high concentrations of Ca
2+
 in the intermembrane space 
(172). Electrochemical proton gradient also plays a pivotal role. This gradient is created 
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by the ETC across the IMM and its predominant part electrical potential serves as a large 
driving force for Ca
2+
 uptake into the matrix (172).  
Figure 3.1. Mitochondrial Ca
2+
 uptake. Ca
2+
 accumulation into mitochondria is 
mediated by MCU, which requires two additional components, VDAC and ETC. Despite 
Ca2+ efflux through Na
+
/Ca
2+
 exchanger (NCX) and H
+
/Ca
2+
 exchanger (HCX), the 
combinatorial actions of MCU, VDAC and ETC allow for effective and rapid Ca
2+
 
uptake by mitochondria. Note that this is an over-simplified cartoon with a focus on 
mitochondrial components of the process. 
 
In brown fat, LRPPRC ablation abrogated the expression of mitochondrial-
encoded ETC subunits and thus complex activities, which collapses the proton gradient, 
and thereby electrical potential is reduced. Due to insufficient driving force, mitochondria 
in brown fat lacking LRPPRC have a decreased ability to accumulate Ca
2+
, leading to 
increased cytosolic Ca
2+
. In IWAT of LRPPRC FTg mice, despite the augmented 
respiratory capacity, paradoxically cytosolic Ca
2+
 could be increased, which argues 
against the induction of thermogenic genes such as Ucp1. This seemingly inconsistent 
situation arises due to UCP1 function. Since UCP1 lowers the proton gradient and thus 
weakens driving force for Ca2+ accumulation, increased UCP1 in IWAT of LRPPRC 
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FTg mice can results in increased cytosolic Ca
2+
. However, this is less likely based on the 
following reasoning. At standard temperature for mouse housing, UCP1 protein must be 
modestly active, and thereby its impact on the proton gradient could be also moderate. 
Under this condition, electrical potential is likely to be sufficient to support normal 
calcium buffering by mitochondria. Nonetheless, future study is required to explore the 
effect of augmented respiratory capacity on cytosolic Ca
2+
 and the potential role of 
cytosolic Ca
2+
 on thermogenic gene expression in IWAT of LRPPRC FTg mice. 
 
3.3. Other potential mediators of mitochondrial retrograde signaling in brown fat  
While we identified Ca
2+
 as a signal between brown fat mitochondria and the 
nucleus, the partial rescue by Ca
2+
 chelation and relatively modest effects of SERCA2 
knockdown would suggest that other mediators are perhaps involved. Mitochondrial 
respiratory defects are often associated with increased mitochondrial reactive oxygen 
species (ROS), which serves as a downstream signaling molecule (90, 171, 180, 181). 
Although we did not formally assess mitochondrial ROS production in brown fat lacking 
LRPPRC and AA-treated brown adipocytes, mitochondrial superoxide production was 
increased in LRPPRC-deficient HepG2 cells, a human hepatoma cell line (unpublished 
data). Even though it is assumed that mitochondrial ROS levels are elevated by AA 
treatment, our preliminary data show that ROS scavengers including N-Acetylcysteine 
(NAC) and MnTMPyP fail to rescue the effects of AA on thermogenic genes in cultured 
brown adipocytes, excluding ROS as a signaling mediator. Even so, mitochondrial ROS 
would be worth further investigation in LRPPRC FKO mice. Additionally, given that 
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cold exposure increases mitochondrial ROS, an induction that is necessary for 
thermogenic energy expenditure and UCP1 function (182), brown fat may use ROS as an 
effector under a defined circumstance. If this is true, it would be quite interesting to 
identify how brown fat distinguishes the two different ROS-producing contexts.  
Mitochondrial respiration directly contributes to the pools of cellular NAD
+ 
 by 
oxidizing a reducing equivalent NADH to NAD
+
 via ETC. NAD+ is recycled in the TCA 
cycle to generate NADH. In addition, NAD
+
 serves as an obligate cofactor of sirtuins and 
PARPs. In mice with loss of PARP-1, a major cellular NAD
+
 consumer (183), NAD
+
 
levels in brown fat was increased and thus sirtuin 1 (SIRT1) activity was induced (184). 
Activated SIRT1 deacetylated PGC-1, which was sufficient to induce many oxidative 
genes and several thermogenic genes including Ucp1 and Dio2 in brown fat (184). 
However, SIRT1 KO mice showed no significant difference in UCP1 protein expression 
in brown fat compared to WT mice (185). This would argue against an essential role of 
SIRT1 in maintaining the key thermogenic program. Similarly, although forced 
expression of sirtuin 3 (SIRT3), a mitochondrial NAD
+
-dependent deacetylase, was 
sufficient to increase expression of Ucp1, Ppargc1a and several respiratory genes in 
brown adipocytes (186), SIRT3 KO mice exhibited normal expression of thermogenic 
and oxidative genes in brown fat (NCBI Accession number GSE27309, (187)). The role 
of other NAD
+
-dependent surtuins in the thermogenic gene program remain elusive.  
Respiratory defects through mtDNA depletion or complex III inhibitors have been 
shown to inhibit pyrimidine (uridine, cytidine) biosynthesis (188, 189). In particular, 
protein levels of p53 were elevated in response to complex III inhibitors, which was 
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rescued not by ROS scavengers but by uridine supplementation. This finding suggests 
that a certain type of mitochondrial retrograde signal is transmitted via depletion of the 
pyrimidine pools. It would be interesting to see if supplying exogenous uridine to 
LRPPRC-deficient cells and AA-treated cells can reverse the decreases in thermogenic 
gene expression.  
A previous study on mice with ectopic expression of glycerol 3-phosphate 
dehydrogenase (GPDH, encoded by Gdc-1) raises a potential connection between 
accumulation of lipids and certain thermogenic genes such as Ucp1 in brown fat. GPDH 
is a cytosolic enzyme that is responsible for conversion of a glycolytic intermediate 
dihydroxyacetone phosphate to glycerol 3-phosphate, a backbone for triglyceride 
synthesis. The GPDH transgenic mice exhibited increased lipid deposition in brown fat 
and liver whereas the lipid contents of subcutaneous and visceral white fat were 
decreased (190). This discordant lipid metabolism and the observation that GPDH-null 
mice had normal lipid content (191) suggest that GPDH overexpression promotes lipid 
redistribution between metabolic tissues but does not enhance lipogenesis. The most 
interesting finding is a severe reduction in Ucp1 mRNA levels in brown fat from the 
transgenic mice. Decreased adrenergic tone is unlikely because Ucp1 was almost equally 
induced in WT and the transgenic mice upon cold exposure (190). Based on these data, 
the following model could arise: As seen in COX7RP KO mice and LRPPRC FKO mice, 
impaired mitochondrial respiratory capacity promotes lipid accumulation presumably via 
decreased fatty acid oxidation. The accumulated lipids may in turn activate a pathway 
that negatively influences the thermogenic genes.     
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3.4. Mitochondrial respiration-independent effects of LRPPRC ablation and 
Antimycin A (AA) treatment 
We used LRPPRC ablation and AA treatment for genetic and pharmacological 
impairment of respiratory capacity, respectively. In this section, the potential pitfalls of 
these approaches and possible solutions will be discussed.  
Although controversial, a few studies have suggested that LRPPRC is a dual-
targeted protein that can be located in nuclei as well as mitochondria (192, 193). 
However, as discussed in the introduction (see Chapter 1.3.2.5), it is unlikely that 
depletion of nuclear LRPPRC underlies the attenuation of thermogenic gene expression 
in brown fat lacking LRPPRC. Even so, this issue could be addressed by using LRPPRC 
with mutated nuclear localization signal (NLS). LRPPRC has a weak NLS that is thought 
to support its nuclear localization (193). When LRPPRC with mutated NLS is introduced 
into LRPPRC-deficient brown fat, the mutant protein will only localized to mitochondria 
and this experiment will tell us whether nuclear LRPPRC plays a role in regulating 
thermogenic gene expression.  
Another possibility is that LRPPRC deletion per se may have pleiotropic effects 
that are not mediated by suppressed mitochondrial transcription and impaired 
mitochondrial respiratory capacity. To exclude this possibility, recovering mitochondrial 
transcription in a LRPPRC-independent way can be considered. Hypothetically, 
hyperactive POLRMT mutant could increase the rate of basal mitochondrial transcription 
in the absence of LRPPRC. Practically, mitochondrial topoisomerase 1 (TOP1MT), a 
negative regulator of mitochondrial transcription (194), can be a solution. Compared to 
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LRPPRC single-knockout, double knockout of LRPPRC/TOP1MT will increase the 
availability of mitochondrial transcripts and thus respiratory capacity to some extent, and 
this should at least in part rescue attenuated thermogenic gene expression in brown fat. 
Like other chemical modulators, AA may exert non-specific effects. Any system 
that disables AA action on its primary target (complex III) will be useful addressing this 
issue. Let us assume that there is a mutant subunit of complex III that AA is unable to 
bind and this mutant does not interfere with the enzyme activity. Deleting WT subunit 
and introducing the mutant subunit will ensure that AA is no longer able to inhibit 
complex III. If the effects of AA that we observed are through inhibition of complex III 
and the resultant impairment of respiratory capacity, mutant complex III should block 
AA action on thermogenic genes in brown adipocytes. Alternatively, AA-insensitive 
complex III ortholog from other species will be equally effective. In case of complex I, 
rotenone (complex I inhibitor)-insensitive NADH–quinone oxidoreductase was identified 
in yeasts (195). To the best of our knowledge, it is unknown that AA-insensitive enzyme 
with the same function as complex III exists in other species. 
 
3.5. Quantitative determination of the contribution of PPARto the attenuation of 
thermogenic gene expression  
We examined a subset of genes among a broad array of brown fat-selective genes 
that are known to be regulated by PPAR To quantitatively determine to what 
extent the attenuated thermogenic gene expression is explained by PPAR, further 
investigation is required using a systematic approach.  
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Using the data sets obtained from whole-transcriptome analysis outlined in 
Chapter 3.1, expression profiles of the previously identified brown fat-specific PPAR 
target genes can be collected. These data will reveal the number of the PPAR target 
genes that are down-regulated in LRPPRC-deficient brown fat. Another quantitative and 
comparative analysis of PPAR target gene expression can be performed using PPAR-
deficient brown fat as a reference. Since PPAR ablation causes embryonic lethality (196) 
and even adipose-specific loss leads to abnormal development of brown fat (152, 197), 
PPAR deletion in mature brown fat using an inducible system such as Cre-ERT2 is 
necessary and this model is available (151). Then, gene expression profiles from 
LRPPRC-deficient and PPAR-deficient brown fat can be compared for the brown fat-
specific PPAR target genes. From this comparison, differences in fold changes of each 
gene between the two conditions can be assessed, leading to estimation of PPAR effect 
on the observed changes in LRPPRC-deficient brown fat. 
 
3.6. How is the recruitment of PPAR to the thermogenic enhancers/promoters 
reduced?  
The specific reduction in occupancy of the thermogenic enhancers/promoters by 
PPAR implies that specific factor(s) and/or specific modifications of PPAR or its 
coactivators are likely involved. Besides the roles of PPAR coactivators in its 
recruitment to thermogenic enhancers/promoters, it has been recently shown that EBF2 is 
necessary for the binding of PPAR to those regulatory elements (40), making it a strong 
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candidate. While our preliminary data shows unaltered mRNA levels of Ebf2 in brown fat 
from LRPPRC FKO mice, it is possible that EBF2 proteins are reduced or EBF2 docking 
on its binding sites near PPAR binding sites within the thermogenic 
enhancers/promoters is decreased. Another scenario could be that a post-translational 
modification of the coactivators interferes with binding to PPARa process that may 
dislodge PPAR from the enhancers/promoters. In fact, PGC-1 is known to undergo this 
type of modification, which separates gluconeogenic and mitochondrial functions (198). 
Lastly, a study shows that CDK5-mediated phosphorylation of PPARat serine 273 only 
affects a subset of its target genes (153). While this study showed that the binding of 
phosphorylated PPAR to those gene promoters was unaltered, a novel posttranslational 
modification of PPAR could possibly regulate its thermogenic gene-specific docking.  
 
3.7. What is the potential link between cytosolic Ca
2+
 and PPAR? 
The answer to this question will be most speculative in this chapter because little 
is known about the Ca
2+
 regulation of PPAR. As outlined earlier, the key PPAR 
coactivators including PGC-1, SRC-1/3 are required for PPAR regulation of 
thermogenic genes but not for adipogenic and lipogenic genes (162, 163). Interestingly, 
intracellular calcium is known to regulate abundance or activity of certain coactivators. In 
skeletal muscle, exercise or caffeine treatment, both of which are known to increase 
cytosolic Ca
2
 via ryanodine receptor (RyR)-mediated Ca
2+ 
release from the sarcoplasmic 
reticulum (SR), promote nuclear translocation and expression of PGC-1, resulting in 
increased mitochondrial biogenesis (199, 200). The expression of RyRs are largely 
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restricted to skeletal and cardiac muscle, and Ca
2+ 
outflow from the receptors generates 
so-called ‘calcium spark’ that is a localized rise in cytosolic Ca2+ concentration and 
underlies excitation-contraction coupling in muscle (201). It may be that the 
spatiotemporal patterns of cytosolic Ca2+ increase are different between contracting 
muscle and brown fat with impaired respiratory capacity. This may lead to divergence 
from each other in the regulation of PGC-1possibly via different calcium signaling 
pathways. It would be worthwhile to see if the nuclear translocation of PGC-1 family 
members is decreased in brown fat from LRPPRC FKO mice and SERCA-deficient 
brown adipocytes. 
Ca
2+ 
is also known to control gene expression through Ca
2+
-activated effectors. A 
well-characterized example is nuclear factor of activated T-cells (NFAT). Increased 
cytosolic Ca
2+
 activates the serine/threonine phosphatase calcineurin through a Ca
2+
-
sensing protein calmodulin. Activated calcineurin dephosphorylates NFAT, allowing for 
the nuclear translocation of NFAT to promote target gene expression (202). A similar but 
converse concept could be applied to PPAR. With an assumption that PPAR is 
phosphorylated at unknown residue(s) and the phospho-PPAR has a reduced ability to 
dock on the thermogenic enhancer/promoters, Ca
2+
-regulated kinases such as protein 
kinase C (PKC), Ca
2+
/calmodulin-dependent protein kinases (CaMKs) may serve as a 
link between cytosolic Ca
2+
 and PPAR by phosphorylating PPARat the residue(s). 
 
3.8. Therapeutic implications 
While leveraging uncoupled respiration in brown fat seems a tempting strategy to 
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fight obesity-related diseases, brown fat is scarce or the activity under cold exposure is 
low in morbidly obese humans (53, 54, 203-205). As for the former case, transplantation 
of brown/beige fat derived from patient’s own progenitor cells may be promising as 
immune-deficient mice implanted with capillary-derived human beige adipocytes show 
metabolic improvements when fed a high-fat diet (HFD) (206). With regards to impaired 
brown fat function in obesity and diabetes, a similar association has been reported for 
various animal models including ob/ob mice, db/db mice, SHR/N-cp rats and HFD 
(containing normal amount of sucrose or high sucrose)-fed mice (207-212). In these 
murine models of obesity and diabetes, there is ‘de-browning’ of brown fat, characterized 
by concomitant reduction in UCP1 protein and respiratory complex activities. Similar to 
classical brown adipocytes, beige adipocytes exhibit this type of de-browning in mice fed 
a HFD, implying a shared mechanism for both types of thermogenic adipocytes (213). 
However, we and others here at UMass Medical School have observed that a well-studied 
obesity-prone mouse strain C57BL6/J did not show a decrease in UCP1 expression upon 
HFD feeding. It is probable that the composition of HFD used may have caused this 
discrepancy in HFD response. Notably, a study describing reduced levels of Ucp1 mRNA 
in brown fat of C57BL6/J mice used a HFD supplemented with high sucrose, the 
western-style diet (208) whereas our lab and others used a HFD with regular amount of 
sucrose. It has also known that dietary polyunsaturated fatty acids (PUFAs) promote 
UCP1 expression in mice and rats (214-216); thus combined actions of different nutrients 
may lead to different responses. Alternatively, strain backgrounds could be an important 
variable. Two unrelated mouse strains, namely CD-1 (outbred) and AKR/J (inbred) 
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display the similar de-browning of brown fat in diet-induced obesity (212, 217).  
As detailed earlier, several models and systems from us and others have 
established a causal relationship between mitochondrial respiratory capacity and 
transcription of genes involved in thermogenesis. Impaired respiration in certain models 
of obesity and diabetes may explain impaired transcription of the thermogenic genes. An 
interesting question would be whether the similar crosstalk is present in human obesity. If 
so, altering respiratory capacity may prove promising in restoring brown fat function in 
certain forms of obesity and diabetes. Even if there are no effects on transcriptional 
programs involved in thermogenesis, augmenting respiratory capacity could still 
effectively protect against obesity and diabetes by way of increased respiratory capacity 
and/or by promoting browning of certain fat tissues as shown in LRPPRC FTg mice, 
which in turn would increase thermogenic capacity.  
In humans and rodents, cold exposure and -adrenergic agonists activate brown 
fat to promote energy expenditure (218-224). Many adrenergic receptor (AR) agonists, 
including pan-adrenergic (ephedrine) and 3-adrenergic (CL-316,243, etc.) agonists, 
have been unsuccessful in humans due to either undesirable cardiovascular effects, poor 
oral availability, or in the case of CL-316,243, weak agonism for the human 3-AR (225). 
Recently, a clinical study has shown that a new class of 3-AR agonist increases energy 
expenditure via brown fat-meditated thermogenesis with no significant effect on 
cardiovascular system (226). Based on my dissertation and other work, a mitochondrial 
retrograde signaling interdicts transcription of thermogenic and oxidative genes, 
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contributing to transition to an energy-storing mode. The status of mitochondrial 
respiratory capacity might reveal unanticipated limitations of 3-agonist therapies being 
considered for humans, limitations predicted to manifest wherever there is a respiratory 
defect of brown fat, and altering respiratory capacity may need to be considered as 
adjunctive therapies to either restore or enhance the thermogenic gene program.  
 
3.9. Is augmented respiratory capacity a universal mechanism to trigger browning 
of adipose tissue? 
An EGFP transgene whose configuration is identical to the LRPPRC transgene 
successfully induced EGFP in whole body of a mouse that expresses ubiquitous Cre 
recombinase (Cre) (227). Likewise, LRPPRC in the transgene construct should be 
expressed to a similar extent in any tissue upon excision of LoxP-flanked 
chloramphenicol acetyltransferase (CAT) gene by tissue-specific Cre. However, our 
initial characterization of the LRPPRC conditional transgenic mice through crossing with 
mice expressing a CMV promoter-driven Cre showed that there was differential 
expression of ectopic LRPPRC in various tissues. Others also reported that their 
cyclooxygenase-2 (COX-2) transgene with the equal configuration as the EGFP and 
LRPPRC transgenes was differentially expressed across tissues (228). It is possible that 
the transgenes may be landed on a tissue-dependent silent region of chromatin via 
random insertion. Given the mixed origins of adipose tissue, each depot may have 
different profiles of silent chromatin.  One solution would be to design a targeting vector 
bearing the transgene so that the construct can be inserted into the ubiquitously expressed 
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locus such as ROSA26 (R26), which would allow us to avoid the silent chromatin issue. 
Once these mice are successfully generated, we should be able to determine whether or 
not augmented respiratory capacity is a universal mechanism to trigger browning of 
adipose tissue.  
 
3.10. Bidirectional communication between thermogenic capacity and respiratory 
capacity in brown fat 
This dissertation and other work describe a one-way regulation that the status of 
mitochondrial respiratory capacity dictates thermogenic gene expression.  Interestingly, it 
has been shown that the thermogenic capacity afforded by UCP1 expression also 
communicate with its partner respiratory capacity in brown fat. In UCP1 KO mice, the 
expression of respiratory subunits that consist of complexes I and IV is severely reduced, 
thereby leading to abrogated complex activities (229). Along with these functional 
defects, brown fat mitochondria from UCP1 KO mice have disorganized and less dense 
cristae. This is specific to brown fat because there is no such defect in heart. Overall, this 
intriguing observation indicates that brown fat monitors the status of the mutually 
connected components of thermogenesis to accordingly modulate its function.  
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APPENDIX 
 
NUTRIENT SENSING BY THE MITOCHONDRIAL 
TRANSCRIPTION MACHINERY DICTATES OXIDATIVE 
PHOSPHORYLATION 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The work in this section has appeared in publication in the Journal of Clinical 
Investigation: 
 
Liu L, Nam M, Fan W, Akie TE, Hoaglin DC, Gao G, Keaney JF Jr, Cooper MP.  
J Clin Invest. 2014 Feb;124(2):768-84. 
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Summary 
Sirtuin 3 (SIRT3), an important regulator of energy metabolism and lipid 
oxidation, is induced in fasted liver mitochondria and implicated in metabolic syndrome. 
In fasted liver, SIRT3-mediated increases in substrate flux depend on oxidative 
phosphorylation (OXPHOS), but precisely how OXPHOS meets the challenge of 
increased substrate oxidation in fasted liver remains unclear. Here, we show that liver 
mitochondria in fasting mice adapt to the demand of increased substrate oxidation by 
increasing their OXPHOS efficiency. In response to cAMP signaling, SIRT3 deacetylated 
and activated leucine-rich protein 130 (LRP130; official symbol, LRPPRC), promoting a 
mitochondrial transcriptional program that enhanced hepatic OXPHOS. Using mass 
spectrometry, we identified SIRT3-regulated lysine residues in LRP130 that generated a 
lysine-to-arginine (KR) mutant of LRP130 that mimics deacetylated protein. Compared 
with wild-type LRP130 protein, expression of the KR mutant increased mitochondrial 
transcription and OXPHOS in vitro. Indeed, even when SIRT3 activity was abolished, 
activation of mitochondrial transcription and OXPHOS by the KR mutant remained 
robust, further highlighting the contribution of LRP130 deacetylation to increased 
OXPHOS in fasted liver. These data establish a link between nutrient sensing and 
mitochondrial transcription that regulates OXPHOS in fasted liver and may explain how 
fasted liver adapts to increased substrate oxidation.  
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Introduction 
In normal fasted liver, an increase in ATP-dependent processes (such as 
gluconeogenesis and ureagenesis) and ketogenesis requires substrate oxidation, 
specifically β-oxidation of fatty acids. Presumably, oxidative phosphorylation 
(OXPHOS) must match this increased need for ATP during fasting. Precisely how 
coordination of this kind occurs in vivo remains an open question. Addressing this 
question is important, as several studies imply that a mismatch between substrate 
oxidation and OXPHOS may sustain or exacerbate metabolic disease (230-232). In 
principle, an increase in mitochondrial content (biogenesis) and/or OXPHOS efficiency 
(OXPHOS activity per mitochondrion) could accommodate increased ATP requirements 
in fasted liver. In terms of regulatory control, sirtuin 3 (SIRT3), a mitochondrial sensor of 
nutrients, is an attractive candidate, since SIRT3 influences both substrate oxidation and 
OXPHOS.  
SIRT3 is a mitochondrial NAD
+
-dependent deacetylase that senses nutrient 
deprivation (233). Upon fasting, SIRT3 protein is induced in liver, where it activates 
enzyme systems involved in fatty acid oxidation and ketogenesis (234, 235). Both long-
chain acyl-CoA dehydrogenase (ACADL; also known as LCAD) and 3-hydroxy-3-
methylglutaryl-CoA synthase 2 (HMGCS2) are deacetylated by SIRT3, culminating in 
enhanced β-oxidation of fatty acids and ketogenesis, respectively (234, 235). In cell 
culture, SIRT3 influences energy metabolism; however, different mechanisms have been 
proposed for various cell types (236-239). Nevertheless, whether and how SIRT3 
influences energy metabolism in vivo, and under what biological conditions, remains an 
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open question. Given that SIRT3 is implicated in metabolic syndrome (239, 240), 
resolving this question might explain how defective mitochondria emerge in metabolic 
disease.  
Mitochondrial transcription potently influences energy metabolism (126). The 
basal transcription machinery of mitochondria consists of mitochondrial transcription 
factor B2 (TFB2M) and mitochondrial RNA polymerase (POLRMT) (241-243). The 
basal machinery is activated by mitochondrial transcription factor A (TFAM), which also 
participates in mitochondrial DNA (mtDNA) packaging and replication (244-249). 
Recently, leucine-rich protein 130 (LRP130; official symbol, LRPPRC [leucine-rich PPR 
motif–containing]), a protein implicated in Leigh syndrome (124, 250), was found to 
stimulate transcription of the core mitochondrial machinery and induce mitochondrially 
encoded transcripts (126), including 13 polypeptides that encode core subunits of the 
electron transport chain (86, 251). Independent of mitochondrial biogenesis, LRP130 
induced mitochondrially encoded gene expression, culminating in increased OXPHOS 
efficiency (i.e., greater OXPHOS per mitochondrion). Additionally, cells and liver replete 
with LRP130 had greater β-oxidation of fatty acid (126), which implies that increased 
OXPHOS facilitates greater substrate oxidation. If the transcription machinery of 
mitochondria is activated by nutrient deprivation to enhance energy metabolism, this 
might explain how fasted liver increases its substrate oxidation, a process critical for 
ATP-dependent pathways, such as gluconeogenesis and ureagenesis, as well as for 
ketogenesis.  
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Here, we investigated coordination between nutrient deprivation and OXPHOS 
activity, considering mitochondrial biogenesis and/or OXPHOS efficiency as potential 
mechanisms. We found that normal fasted liver used mitochondria with greater OXPHOS 
efficiency, rather than increasing mitochondrial mass. Greater OXPHOS efficiency was 
achieved by increasing mitochondrial transcription, regulatory control that was dependent 
on SIRT3 and LRP130. In fasted liver, SIRT3 deacetylated and activated LRP130, which 
stimulated mitochondrial transcription to promote OXPHOS. This process was triggered 
by glucagon/cAMP signaling. We propose that the transcription machinery of 
mitochondria senses nutrients via SIRT3, permitting augmentation of OXPHOS. 
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Materials and Methods 
Cell culture and animal experiments  
Stable transduction of H2.35 cells with SIRT3 or LacZ was achieved using 
pQCXIP vectors (Clontech), as previously described (126). H2.35 cells stably expressing 
SIRT3 or LacZ were treated with 500 μM NAD+ 16 hours prior to harvest. Knockdown 
of murine Lrp130 was performed as previously described (123, 160). The shRNA 
sequence targeted against human LRP130 was 5′-ATGTGAGTCACTATAATGCT-3′. 
Primary hepatocytes were isolated from mice as previously described (105). Briefly, 
approximately 400,000 hepatocytes were seeded per well of a 6-well plate and infected 
with adenovirus encoding the gene of interest. Virus sufficient to produce a multiplicity 
of infection of 400 in AD-293 cells (Stratagene, catalog no. 240085) was used to infect 
400,000 hepatocytes. After 16 hours, virus was removed and replaced with fresh medium. 
Hepatocytes were further incubated for 20 hours, after which cells were harvested. For 
transduction of liver, 8 × 10
9
 live adenoviral particles were tail vein injected into 
C57BL/6 mice on day 0 in 100 μl PBS. On day 5, liver tissue was harvested. Mice were 
maintained in 12-hour light/12-hour dark cycle.  
Lrp130
flox/flox
 mice, which harbor loxP sites flanking exons 3 and 4 of Lrp130, 
were generated by the University of Massachusetts Medical School Transgenic Animal 
Modeling Core from KOMP ES cell clone CSD33081. Prior to experimentation, mice 
were backcrossed for at least 8 generations onto the C57BL/6 background. Lrp130
flox/flox
 
mice and wild-type controls aged 8–12 weeks were infected with AAV-Cre at 1.0 × 1011 
GC/mouse in 100 μl PBS. The vector for liver-specific cre recombinase driven by the 
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human thyroxine-binding globulin promoter was packaged in adeno-associated virus by 
the Viral Vector Core of the University of Massachusetts Medical School as previously 
described (252). 3 weeks after injection, mice were singly housed beginning at 10 AM for 
exactly 24 hours in a fed or fasted state, after which they were euthanized for protein and 
genetic studies. Pgc1a
flox/flox
 mice (The Jackson Laboratory, stock no. 009666) were 
injected with AAV-Cre as described above. 3 weeks after infection, primary hepatocytes 
were isolated for experimentation. All animal experiments were approved by the IACUC 
of University of Massachusetts Medical School. 
Assessment of mitochondrial mass using MitoTracker Green FM 
Mitochondrial mass was evaluated by flow cytometric analysis of cells stained 
with MitoTracker Green FM (Invitrogen). Briefly, cells were stained with Mitotracker 
Green FM at 100 nM for 30 minutes at 37°C. Cells were rinsed with PBS, trypsinized, 
and centrifuged at 130 g for 4 minutes. Cell pellets were resuspended in PBS containing 
1% FBS for FACS. To quantify mitochondrial mass, 20,000 live cell counts were gated. 
Since MitoTracker Green FM is excited at 490 nm and emits at 516 nm, the FITC 
channel (excitation at 494 nm, emission at 520 nm) was used to detect signal.  
 
Quantification of transcription and RNA degradation in whole cells 
4sU was used to quantify transcription and RNA degradation as previously 
described (253), with some modifications. For transcription assays, 1.77 × 10
6
 H2.35 
cells stably expressing LacZ or SIRT3 were plated in 10-cm dishes and allowed to attach 
overnight. Cells were treated with 500 μM NAD+ for 16 hours and labeled with 2 mM 
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4sU (Sigma-Aldrich, catalog no. T4509) for 15 minutes at 37°C. RNA was isolated from 
cells using Trizol and Qiagen’s RNeasy mini kit. 50 μg RNA was labeled with EZ-link 
Biotin-HPDP for 1.5 hours at room temperature. Unbound Biotin-HPDP was removed by 
chloroform/isoamylalcohol (24:1) extraction at 16,000 g for 5 minutes. A 1:10 volume of 
5 M NaCl and an equal volume of isopropanol were added. Precipitated RNA was 
pelleted at 16,100 g for 20 minutes at 4°C. The pellet was washed with 75% ethanol and 
again pelleted at 16,100 g for 5 minutes at 4°C. The pellet was resuspended in 100 μl TE 
buffer (10 mM Tris-Cl pH 8.0, 1 mM EDTA). RNA samples were denatured at 65°C for 
10 minutes, then rapidly cooled on ice for 5 minutes. Subsequently, denatured 
biotinylated RNA was captured using Dynabeads M-270 streptavidin (Invitrogen) with 
rotation at room temperature for 15 minutes. Beads were washed 3 times with 55°C wash 
buffer (100 mM Tris pH 7.5, 10 mM EDTA, 1 M NaCl, 0.1% Tween-20), followed by 3 
washes at room temperature. Biotin-labeled RNA was eluted with 100 mM DTT by 
rotating at room temperature for 10 minutes. De novo transcripts were cleaned up using 
Qiagen’s RNeasy mini kit. Recovered transcripts were quantified using Ribogreen 
(Invitrogen). Approximately 120 ng RNA was used for reverse transcription and 
subsequent qPCR (RT-qPCR). To assess specificity, a reaction containing no 4sU label 
was performed in parallel. In general, 4sU transcripts were enriched more than 60-fold.  
For RNA degradation studies, on day 0 at 9 AM, H2.35 cells stably expressing 
LacZ or SIRT3 were plated at a density of 2.8 × 10
5
 cells/well of a 6-well plate. On day 1 
at 9 AM, cells were labeled with 0.1 mM 4sU, labeling that continued for 24 hours. On 
day 1 at 5 PM, labeling medium was supplemented with 500 μM NAD+. The 0-hour time 
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point was defined as 9 AM on day 2. At the 1- and 2-hour time points, cells were washed 
with PBS, after which medium containing 20 mM uridine (Sigma-Aldrich, catalog no. 
U3003) was used to chase the 4sU label. RNA harvesting and processing proceeded as 
described above.  
 
Immunopurification of acetylated proteins and detection of acetylated LRP130 
protein 
Acetylated proteins were immunopurified as previously described (254). Briefly, 
crude mitochondria were extracted from approximately 400 mg of mouse liver, then 
frozen on liquid nitrogen. The frozen mitochondrial pellet, about 100 μl volume, was 
lysed in 500 μl FLAG lysis buffer (50 mM Tris-Cl pH 7.8, 137 mM NaCl, 10 mM NaF, 1 
mM EDTA, 1% Triton X-100, 0.2% sarkosyl, 10% glycerol) supplemented with 10 μM 
TSA and 5 mM nicotinamide. The typical lysate yielded a protein concentration of about 
5 mg/ml. 2–10 mg mitochondrial lysate was incubated with 30 μl anti–acetylated lysine 
antibody–conjugated beads (Immunechem, catalog no. ICP0388) at 4°C overnight. The 
beads were washed with FLAG lysis buffer 4 times, 1 minute per wash, at room 
temperature. Acetylated protein was eluted with 49 μl freshly prepared glycine (0.1 M, 
pH 2.5) for 5–10 minutes at room temperature. 1 elution usually proved sufficient, 
yielding the highest protein concentration. 1 μl saturated Tris, prepared by dissolving Tris 
base in ddH2O until saturated, was added to the eluate to achieve a pH of 7.0. To detect 
acetylated LRP130 protein, immunoenriched acetylated fractions were immunoblotted 
for LRP130 using anti-LRP130 rabbit polyclonal sera, as previously reported (126).  
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qPCR of mtDNA content and RT-qPCR 
To isolate total DNA, approximately 20 mg frozen liver was lysed in 200 μl tissue 
lysis buffer (50 mM Tris-Cl pH 7.5, 50 mM EDTA pH 8.0, 100 mM NaCl, 1% Triton X-
100, 5 mM DTT, 100 mg/ml proteinase K) at 56°C overnight. The lysate was extracted 
once with phenol/chloroform, after which the aqueous phase was precipitated with 0.1 
volumes of 3 M sodium acetate (pH 5.2) and 2.5 volumes of 100% ethanol. Total DNA 
was quantified using Quant-iT Picogreen dsDNA assay kit (Invitrogen). In a qPCR 
reaction volume of 15 μl, 400 pg total DNA was used to quantify mtDNA content. 
Showing strong agreement, 4 mtDNA genes — ND1, ND6, ATP6, and COX1 — were 
used to quantify mtDNA content. 18S and 28S rRNA served as nuclear reference genes 
(unless otherwise indicated). In addition, Tbp served as a reference gene (unless 
otherwise indicated); however, 10 ng total DNA in a reaction volume of 15 μl was used. 
For RT-qPCR, total RNA was isolated and processed as previously described (126). See 
Tables A.S2 and A.S3 for primers.  
 
Citrate synthase activity in whole liver homogenate 
Citrate synthase assay was performed as previously described (255), with slight 
modifications. 30 mg frozen liver was placed in 300 μl RIPA buffer (50 mM Tris-Cl pH 
7.4, 150 mM NaCl, 5 mM EDTA pH 8.0, 0.1% SDS, 1% sodium deoxycholate, 1% 
NP40) supplemented with PMSF and protease inhibitor cocktail (Sigma-Aldrich), 
followed by homogenization using a bead-mill homogenizer (Qiagen GmbH) at 25 Hz for 
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120 seconds. The liver homogenate was incubated on ice for 30 minutes, then centrifuged 
at 16,100 g for 10 minutes at 4°C. The protein concentration of the cleared homogenate 
was determined using a BCA kit (Thermo Scientific). 10 μg protein was loaded in citrate 
synthase assay buffer (100 mM Tris-Cl pH 8.0, 0.1 mM DTNB, 0.1 mM acetyl-CoA). 
The reaction was started by adding 0.25 mM freshly prepared oxaloacetate. A blank 
sample contained all reagents except liver homogenate. The increase in absorbance due to 
the formation of 5-thio-2-nitrobenzene anion at 412 nm was measured every 30 seconds 
for 15 minutes at room temperature. The activity of citrate synthase was expressed as the 
blank-corrected slope of the absorbance versus time plot within the linear range. Activity 
was presented as absorbance units per second per milligram protein (AU/s•mg protein), 
obtained by multiplying AU/s•10 μg protein by 1,000 μg/mg protein.  
 
Cloning and construction of LRP130-7KR 
Lysine-to-arginine (KR) mutations were made using a Quick Change II XL site-
directed mutagenesis kit (Stratagene, catalog no. 200521). First, a 5KR mutant (K1036R, 
K1059R, K1250R, K1348R, and K1355R) was generated by serially mutating a C-
terminal fragment of LRP130 (1,011–1,392 aa) contained in the pET30a vector. After 
PCR amplification, the mutated fragment was digested with BlpI/PacI and ligated into the 
BlpI/PacI site of a pQCXIP vector encoding full-length murine LRP130. Second, a 2KR 
mutant (K225R and K452R) was generated by serially mutating an N-terminal fragment 
of LRP130 (60–1,010 aa) contained in the pET30a vector. After PCR amplification, the 
fragment was digested with BspE1 and ligated into the BspE1 site of LRP130-
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5KR/pQCXIP, yielding LRP130-7KR (K225R, K452R, K1036R, K1059R, K1250R, 
K1348R, and K1355R). Confirmation of mutations was assessed using Sanger method 
sequencing. 
 
Cloning and construction of LRP130-7KQ 
Lysine-to-glutamine (KQ) mutations were made using a Quick Change II XL site-
directed mutagenesis kit (Stratagene, catalog no. 200521). First, a 2KQ mutant (K1036Q 
and K1250Q) was generated by serially mutating a C-terminal fragment of LRP130 
(1,011–1,392 aa) contained in the pET30a vector. After PCR amplification, the mutated 
fragment was digested with BlpI/PacI and ligated into the BlpI/PacI site of a pQCXIP 
vector encoding full-length murine LRP130. Second, we removed a segment of the above 
LRP130-2KQ/pQCXIP plasmid by digestion with SnaBI, yielding the 7.6-kb truncation 
product LRP130-2KQ/ΔpQCXIP. Then, 3 additional C-terminal KQ mutations (K1059Q, 
K1348Q, and K1355Q) were generated by serially mutating the LRP130-2KQ/ΔpQCXIP 
vector. This mutated fragment was digested with XhoI/PacI and reinserted into a 
similarly digested, full-length LRP130/pQCXIP vector, producing a 5KQ mutant of 
LRP130. A third 2KQ mutant (K225Q and K452Q) was generated by serially mutating 
an N-terminal fragment of LRP130 (60–1,010 aa) contained in the pET30a vector. After 
PCR amplification, the fragment was digested with BspE1 and ligated into the BspE1 site 
of LRP130-5KQ/pQCXIP, yielding LRP130-7KQ (K225Q, K452Q, K1036Q, K1059Q, 
K1250Q, K1348Q, and K1355Q). Confirmation of mutations was assessed using Sanger 
sequencing. 
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Purification of recombinant proteins 
For purification of LRP130 fragments contained in pET30a, a single colony was 
cultured in 6 ml kanamycin LB media at 37°C overnight. 5 ml of overnight culture was 
transferred into 100 ml of LB media and shaken at 37°C for 3 hours until OD600 was 
about 0.4. The culture was then induced with 1 mM IPTG for 5 hours at 37°C. Bacteria 
were harvested by centrifugation at 1,500 g for 15 minutes, and the pellet was frozen at –
80°C until further processing. After thawing, the pellet was resuspended in 10 ml lysis 
buffer (50 mM NaH2PO4, 300 mM NaCl, 10 mM imidazole, 0.5 mM PMSF, pH 8.0). 1 
mg/ml lysozyme and 100 μl of 10% Triton X-100 was added into the lysis buffer and 
incubated at 37°C for 10 minutes. Bacterial DNA was sheared by sonicating (Sonic 
Dismemberator 60, Fisher, maximum output) twice for 10 seconds. Cell debris was 
pelleted at 9,300 g for 20 minutes at 4°C. 100 μl Ni-NTA beads were added to the 
supernatant and incubated at 4°C overnight. The beads were washed 3–4 times with 1 ml 
wash buffer (50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0), 1 minute 
each, at room temperature. His-tagged LRP130 protein was eluted 2 hours at 4°C with 
elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole). The buffer was 
exchanged to BC100 (100 mM NaCl, 20% glycerol, 20 mM Tris-Cl pH 7.9, 0.1% NP-40) 
using a NucAway spin column (Invitrogen).  
 
For purification of CBP-GST fusion protein, E. coli Rosetta (DE3) cells were 
transformed with plasmid encoding CBP-HAT-GST (pGEX-4T1-CBP-HAT). Bacteria 
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were cultured in 6 ml LB medium containing carbencillin (100 μg/ml). After overnight 
culture at 37°C with vigorous shaking, 1,000 ml fresh LB medium was inoculated, and 
bacteria were allowed to grow for 3–5 hours, until OD600 reached 0.4–0.6. Expression of 
GST-CBP fusion protein was induced with overnight at room temperature using 0.5 mM 
IPTG. Bacteria were harvested by centrifugation at 1,500 g for 15 minutes. The pellet 
was resuspended in 10–15 ml ice-cold PBS and an equal volume of BC100 buffer. 
Following sonication, Triton X-100 was added until reaching a final concentration of 1%. 
Lysates were clarified at 13,300 g for 30 minutes. The supernatant was transferred to a 
new tube. 100 μl glutathione agarose beads (Pierce, catalog no. 16110) was added to the 
supernatant and incubated at 4°C overnight. The beads were washed 3 times with 20 ml 
BC500 (500 mM NaCl, 20% glycerol, 20 mM Tris-Cl pH 7.9, 0.1% NP-40) and 2 times 
with 20 ml BC100. GST-tagged CBP protein was eluted for 2 hours at 4°C with 20 mM 
reduced glutathione (Thermo Scientific, catalog no. 78259).  
 
In vitro acetylation and deacetylation assays 
Acetylation reactions of 10 μl volume contained 50 mM HEPES (pH 8.0), 10% 
glycerol, 1 mM DTT, 1 mM PMSF, 10 mM sodium butyrate, 100 μM acetyl-CoA, 2 μg 
LRP130 purified protein, and 100 ng CBP-HAT domain protein (1,319–1,710 aa). The 
reaction mixture was incubated at 30°C for 1.5 hours. Subsequently, an equal volume of 
2× LDS loading buffer was added, and the reactions were analyzed by immunoblotting 
overnight at 4°C with anti–acetylated lysine antibody (Cell Signaling, catalog no. 9441). 
For in vitro deacetylation assay, acetylated LRP130 protein was recovered by binding to 
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Ni-NTA beads (Qiagen, catalog no. 30410) and washed 3–4 times with 1 ml wash buffer 
(50 mM NaH2PO4, 300 mM NaCl, 20 mM imidazole, pH 8.0), 1 minute per wash, at 
room temperature. Acetylated LRP130 protein was eluted with 50 μl of 250 mM 
imidazole at 4°C for 2 hours. The elution buffer was changed to BC100 using a 
NucAway spin column (Invitrogen). Deacetylation was performed in a 20-μl reaction 
containing approximately 1 μg acetylated LRP130 protein, 2 μl purified SIRT3 (Cyclex 
kit, catalog no. CY-1153), and 500 μM NAD+. The reactions were incubated at 30°C for 
1.5 hours in a buffer containing 50 mM Tris-HCl (pH 9.0), 50 mM NaCl, 4 mM MgCl2, 
0.5 mM DTT, 0.2 mM PMSF, 0.02% NP-40, and 5% glycerol. Subsequently, the reaction 
was stopped by adding 4× LDS loading buffer, and the reactions were analyzed by 
immunoblotting overnight at 4°C using anti–acetylated lysine antibody (Cell Signaling, 
catalog no. 9441).  
 
Identification of peptides using tandem mass spectrometry 
Mass spectrometry studies were performed at the Proteomics and Mass 
Spectrometry Facility of University of Massachusetts Medical School, as previously 
reported (256). In brief, silver stained gel bands were rinsed in water and briefly 
incubated with ammonium bicarbonate (100 mM). Gel bands were next destained with a 
1:1 ratio of potassium ferricyanide (30 mM) and sodium thiosulfate (100 mM), and 
transferred to new tubes containing 1 ml water for 1 hour. After removal of the water, gel 
slices were subjected to addition of 50 μl of 250 mM ammonium bicarbonate, reduced 
with 5 μl of 45 mM DTT for 30 minutes at 50°C, and then alkylated with 5 μl of 100 mM 
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iodoacetamide for 30 minutes at room temperature. The slices were then washed twice 
with 1 ml water, incubated in a 1:1 solution of 50 mM ammonium 
bicarbonate/acetonitrile at room temperature for 1 hour, soaked in 200 μl acetonitrile, 
removed, and dried in a SpeedVac. Samples were then digested with 50 μl of 2 ng/μl 
trypsin (Sigma-Aldrich) in 0.01% ProteaseMAX Surfactant (Promega) in 50 mM 
ammonium bicarbonate at 37°C for 21 hours. The supernatant of each sample was then 
removed and placed in a separate 0.5-ml tube, and each slice was further extracted with 
100 μl acetonitrile/1% (v/v) formic acid (4:1), combined with respective supernatants of 
each sample, taken to dryness in a SpeedVac, and reconstituted in 20 μl of 0.1% TFA. 
LC-MS/MS analysis was done on a LTQ Orbitrap Velos mass spectrometer (Thermo 
Scientific) as previously reported (256), with the exception of using a 90-minute gradient 
for peptide elution. Raw data files were processed with either Mascot Distiller (Matrix 
Science) or Extract_MSN (Thermo Scientific), searched against the SwissProt database 
using the Mascot Search engine (Matrix Science). In brief, parent mass tolerances were 
set to 10 ppm, while fragment mass tolerances were set to 0.5 Da. Full tryptic specificity 
with 2 missed cleavages was used, and variable modifications of acetylation (protein N-
term, lysine), pyro-glutamination (N-term glutamine), oxidation (methionine), and 
carbamidomethylation (cysteine) were considered. Further peptide annotation was 
achieved using Scaffold (Proteome Software), while relative quantification of acetylated 
peptides was performed using ProteoIQ (Nusep Inc.). Spectra of acetylated peptides were 
manually inspected to further validate assignments.  
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Metabolic labeling of mitochondrial proteins 
Mouse primary hepatocytes were isolated as previously described (160). Cells 
were seeded in 6-well plates at 4.5 × 10
5
 cells/well. After 16 hours, cells were treated 
with vehicle or 20 nM glucagon (Bachem) for 24 hours in starvation media (DMEM, 
0.2% BSA, 2 mM sodium pyruvate). Cells were pretreated with 100 μg/ml 
cycloheximide (Sigma-Aldrich) and/or 100 μg/ml chloramphenicol (Sigma-Aldrich) as 
indicated for 10 minutes in methionine and cysteine-free starvation media containing 
vehicle or glucagon. Cells were then labeled with [
35
S]-methionine and [
35
S]-cysteine (50 
μCi/ml, PerkinElmer) for 60 minutes and chased for 10 minutes in regular DMEM. Cells 
were washed with PBS twice and lysed in RIPA buffer supplemented with protease 
inhibitor cocktail (Sigma-Aldrich), followed by 3 freeze-thaw cycles. Lysates were 
cleared by centrifugation at 16,100 g for 10 minutes at 4°C. Protein concentration was 
determined by BCA assay (Thermo Scientific). 80 μg of protein (20 μg for total 
translation) were separated on a 15% polyacrylamide gel at 50 mA. The gel was fixed 
and stained using colloidal blue staining kit (Invitrogen) to confirm equal protein loading. 
The gel was then dried at 70°C for 3 hours and exposed to a Biomax MR film 
(Carestream Health). Radioactivity in 5 μl of lysates was quantified using a liquid 
scintillation counter (Beckman Coulter) and normalized to protein concentration.  
 
Palmitate oxidation assay 
Palmitate oxidation was performed as previously described (126). Briefly, H2.35 
mouse hepatoma cells were incubated in starvation medium (1% BSA, 25 mM HEPES, 1 
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mM sodium pyruvate in DMEM) in the presence of 0.5 mM NAD
+
 for 16 hours. Cells 
were then incubated for 2 hours in preincubation medium (1% BSA, 25 mM HEPES, 
0.25 mM sodium palmitate, 0.5 mM carnitine in DMEM), and subsequently, 0.5 μCi/well 
of 14C-palmitate was added for 90 minutes. The plate was frozen in liquid nitrogen, and 
250 μl perchloric acid was added to each well. Filter paper moistened with 3N NaOH was 
immediately placed over each well and released CO2.  
 
Comparison of acetylated LRP130 sites across studies 
To estimate the probability that, by chance, 2 studies (Study A and Study B) 
would identify a given number of acetylated residues in common, we used the 
hypergeometric distribution. If, of a total N acetylated LRP130 peptides, Study A 
identified a peptides and Study B identified b peptides, the probability that the sets of 
peptides identified by the 2 studies would have exactly c peptides in common, 0 ≤ c ≤ 
min(230), is as follows.  
 
(Equation 1) 
Derivation. Conditioning on the peptides identified in Study A induces a separation of the 
peptides in Study B into 2 groups: the a peptides identified in Study A and the N – a 
peptides not identified in Study A. If the 2 studies identify exactly c peptides in common, 
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Study B must identify c peptides among the a peptides and its remaining b – c peptides 
among the N – a peptides. The number of ways in which this can occur is the product of 
the binomial coefficients in the numerator. The total number of ways in which Study B 
can identify b peptides among the N is equal to the binomial coefficient in the 
denominator. This conditional probability applies to each of the possible sets of a 
peptides that Study A could identify. Because those sets are equally likely, the 
conditional probability is also the unconditional probability. 
Assumptions. The application of the probabilities assumes there are 102 potentially 
acetylatable lysine residues in LRP130 and that, if acetylated, each residue would have 
equal probability of detection by mass spectrometry. It also assumes that mass 
spectrometry of LRP130 protein approaches 100% for each study. Because these 
conditions may not hold for every study, the probabilities are approximations. 
 
Domain mapping and in vitro binding assay 
Truncated mouse POLRMT clones expressing aas 1–340, 1–500, 1–650, and 1–
710 were each generated by PCR. The products of these reactions were digested with 
BamHI and XbaI, then ligated in frame into pcDNA3.1 myc His B plasmid. Clones 
containing full-length and truncated POLRMT were subjected to in vitro 
transcription/translation using a TnT kit (Promega, catalog no. L4610). Full-length mouse 
LRP130 fused with an S-tag was immobilized on S-protein agarose (Novagen, catalog 
no. 69704), then washed with 25 mM HEPES and 0.125% Tween20 containing protease 
inhibitors. The translated products were subsequently treated with DNaseI and RNase for 
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10 minutes at room temperature and centrifuged for 10 minutes at 15,700 g at 4°C. The 
supernatants were incubated with immobilized S-tag LRP130 agarose. After incubation 
for 2 hours at 4°C, complexes were extensively washed with 25 mM HEPES, 0.125% 
Tween-20, and 0.125 M KCl, and c-myc was detected by immunoblotting.  
 
Cellular respiration, complex activity, and isolation of mitochondria 
Cellular respiration (123, 126), isolation of mitochondria (123, 126, 160), 
complex activity (126), and fractionation of mitochondria by alkaline treatment (257) 
were performed as previously described.  
 
Statistics 
2-tailed Student’s t tests were used to analyze complex activity, mitochondrial 
content (using measures of mtDNA or fluorescence), protein quantification, and cellular 
respiration data. P values less than 0.05 were considered significant. 2-way ANOVA was 
used to assess differences in gene expression. Because mitochondrially encoded genes are 
transcribed as long polycistronic transcripts and thus tightly coordinated as a “gene set,” 
we evaluated the entire set using a 2-way ANOVA, reporting a P value comparing 
differences among various groups (or treatments). P values less than 0.05 were 
considered significant. In contrast, nuclear-encoded genes were subjected to post-hoc 
analyses (as indicated in the figure legends), since they are not polycistronic genes that 
do not necessarily fit into a specific gene set. For these studies, Bonferroni-corrected 
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post-tests were implemented using a multiple comparison–adjusted α. All analyses were 
conducted using GraphPad Prism version 6.00.  
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Results 
In liver, fasting coordinately induces mitochondrially encoded transcripts and 
OXPHOS capacity  
Fasted liver is notable for ATP-consuming processes, and is thus dependent on 
OXPHOS. Given that induction of mitochondrially encoded transcripts stimulates 
OXPHOS, we wondered whether mitochondrially encoded transcripts and OXPHOS are 
coordinately induced in fasted liver of C57BL/6 mice. After fasting for 24 hours, mouse 
liver showed modestly increased mitochondrially encoded transcripts and OXPHOS 
capacity (Figure A.1A and C). Indicative of a normal fasted response, mRNA of Pepck 
and G6p, enzymes involved in gluconeogenesis, was induced, whereas that of Scd1 and 
Fasn, enzymes involved in lipogenesis, was attenuated (Figure A.1B). Interestingly, the 
increase in complex IV activity that we observed (Figure A.1C) paralleled that reported 
by another group; however, alterations in mitochondrial content were not explored in the 
previous report (258).  
Conceivably, changes in mitochondrially encoded transcripts and OXPHOS might 
be explained by increased mitochondrial content. We therefore quantified mitochondrial 
biogenesis using complementary genetic, biochemical, and protein assessments. While 
mRNA for Pgc1a, a potent regulator of mitochondrial biogenesis, was induced, there was 
no induction of Tfam, Polrmt, and Tfb2m, which comprise the basal transcription 
machinery of mitochondria, or of Lrp130, which stimulates the core machinery (Figure 
A.1B).  Because genes comprising the basal transcription machinery are induced during 
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Figure A.1. Fasting coordinately induces mitochondrially encoded transcripts and 
OXPHOS in liver. (A) Hepatic gene expression of mitochondrially encoded transcripts 
in 24-hour fasted or fed C57BL/6 mice (n=3). (B) Expression of genes that regulate 
mitochondrial biogenesis, mitochondrial transcription, lipogenesis, and gluconeogenesis 
(n=3). (C) Complex activity of mitochondria isolated from liver of 24-hour fasted or fed 
C57BL/6 mice (n=3). CI–CV, complexes I–V; CS, citrate synthase. (D) Biochemical 
assessment of mitochondrial content using citrate synthase activity in whole liver 
homogenate (n=3). (E) Genetic assessment of mitochondrial content using mtDNA 
content (n=3). (F) Assessment of mitochondrial content by immunoblotting citrate 
synthase protein in whole liver homogenate (n=3–4). Data are mean ± SEM. *P < 0.05, 
**P < 0.01, ***P < 0.001, 2-way ANOVA, with (B and C) or without (A) Bonferroni 
post-test, or 2-tailed unpaired Student’s t test (D and E).   
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mitochondrial biogenesis, their lack of induction was indicative of stable mitochondrial 
content. mtDNA content was unchanged (Figure A.1D), in support of unaltered 
mitochondrial mass. Because the activity of citrate synthase proved indistinguishable in 
isolated mitochondria (Figure A.1E), its activity in whole-liver homogenate permitted 
biochemical assessment of mitochondrial content. In agreement with genetic data, the 
activity and protein level for citrate synthase were unchanged (Figure A.1E and F), 
indicative of stable mitochondrial content regardless of feeding status. Hence, induction 
of Pgc1a was not associated with altered mitochondrial content in fasted liver. As 
previously reported in other systems (259, 260), these data imply that a certain threshold 
effect of PGC-1α coactivator activity is necessary to induce mitochondrial biogenesis.  
Next, we sought to understand which nutrient signaling pathway influences 
mitochondrially encoded gene expression. Broadly, the fasting response is notable for a 
decline in insulin and an increase in glucagon, the latter of which activates intracellular 
cAMP signaling. Using cultured primary hepatocytes, we evaluated these possibilities. 
Withdrawal of insulin had no effect on the fasting-responsive genes Pepck and G6p or on 
mitochondrially encoded genes (Figure A.2A and C). As reported by others, glucagon 
induced both Pepck and G6p (Figure A.2C). Interestingly, mitochondrially encoded 
genes were also induced, while many nuclear encoded ETC genes were unaffected 
(Figure A.2A and B). Forskolin, which increases intracellular cAMP levels, induced 
mitochondrially encoded genes as well (Figure A.S1A and B), which indicates that the 
cAMP pathway governed by glucagon is likely responsible. Even in Pgc1a null primary 
hepatocytes, glucagon was still sufficient to induce mitochondrially  
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Figure A.2. Glucagon induces mitochondrially encoded genes and proteins. (A) 
Neither insulin/dexamethasone (Insulin+Dex) nor their withdrawal (Vehicle) had an 
effect on mitochondrially encoded gene expression; however, glucagon induced 
mitochondrially encoded gene expression. (B) Effect of glucagon on several nuclear 
encoded ETC subunits. (C) Effect of glucagon on fasting-responsive genes and regulators 
of mitochondrial content and function. (D) [
35
S]-methionine labeling of cytoplasmic 
proteins (left 2 lanes) and mitochondrially encoded translation products, which were 
evident after inhibition of cytoplasmic translation with cycloheximide (CHX) (middle 6 
lanes). Consistent with mitochondrial translation products, chloramphenicol (CAP) 
blocked their translation (right 2 lanes). GCG, glucagon. (E) Coomassie brilliant blue 
staining of the [
35
S]-labeled gel, showing equal protein loading. (F) Quantification of 
mitochondrially encoded [
35
S]-labeled proteins by scintillation courting (n = 3). Data are 
mean ± SEM. **P < 0.01, ***P < 0.001, 2-way ANOVA, with (B and C) or without (A) 
Bonferroni post-test, or 2-tailed unpaired Student’s t test (F).  
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encoded genes, although the response was modestly blunted (Figure A.S1C and D). 
These data further support the observation that de novo biogenesis is not required. 
Induction of mitochondrially encoded genes was accompanied by an increase in 
mitochondrially encoded proteins (Figure A.2D–F). Even so, in both primary mouse 
hepatocytes and mouse liver, gene expression was largely unchanged for several nuclear 
encoded ETC subunits (Figure A.2B and Figure A.3A). Several nuclear encoded ETC 
proteins, however, were increased in fasting liver mitochondria (Figure A.3B and C), 
which indicates that they were modestly stabilized (or more efficiently translated) in the 
fasted state. Overall, these data are suggestive of a coordinated response that facilitates 
enhanced OXPHOS. Importantly, mitochondrially encoded proteins, which are central to 
the process, are regulated at the level of gene expression.  
Finally, we used a different mouse strain to test the generality of the response. 
Similar to C57BL/6 mice, mitochondrially encoded genes were increased in 129S mice 
(Figure A.S2), although the induction of Pepck, G6p and other genes was less robust. 
Similar to C57BL/6 mice, induction of mitochondrially encoded genes in 129S mice was 
not attributable to alterations in mitochondrial content (Figure A.S2). These observations 
indicated that the fasting response is accompanied by increases in mitochondrially 
encoded transcripts and OXPHOS, independent of de novo mitochondrial biogenesis. 
Given that increased mitochondrially encoded gene expression enhances OXPHOS (126), 
these data might imply that induction of mitochondrially encoded genes in cooperation 
with nuclear encoded subunits increases the capacity for OXPHOS in fasted liver.  
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Figure A.3. Glucagon-mediated induction of mitochondrially encoded genes 
requires SIRT3. (A) Fasted mouse liver showed no change in gene expression for 
several nuclear encoded ETC genes (n=3–4). (B) Representative immunoblot of several 
nuclear encoded ETC subunits. Freshly isolated mitochondria were alkaline extracted 
with carbonate buffer, permitting assessment of the membrane fraction (Pellet) or soluble 
fraction. (C) Quantification of the several nuclear encoded ETC subunits (n=3–4). (D–H) 
In Sirt3 knockout primary hepatocytes, glucagon-mediated induction of fasting-
responsive genes was unaltered (D); however, induction of mitochondrially encoded gene 
expression was completely abrogated (E; n=3) and no longer accompanied by increased 
mitochondrially encoded translation products (F and H). (G) Coomassie brilliant blue 
staining of [
35
S]-labeled gel, showing equal protein loading. Similar results were obtained 
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using nicotinamide (Figure A.S1E and F). Data are mean ± SEM, except in C (mean ± 
SD). *P < 0.05, **P < 0.01, ***P < 0.001, 2-way ANOVA with Bonferroni post-test (A, 
D, and E) or 2-tailed unpaired Student’s t test (C and H).  
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SIRT3 is necessary and sufficient for fasting-mediated induction of mitochondrially 
encoded transcripts and OXPHOS 
By sensing the level of cellular NAD
+
, sirtuins are important sensors of nutrient 
deprivation. To globally assess this, we treated primary hepatocytes with nicotinamide, 
which inhibits NAD
+
-dependent sirtuin activity, and evaluated the response to glucagon. 
Nicotinamide had no effect on the fasting-responsive genes Pepck and G6p (Figure 
A.S1E). In contrast, nicotinamide abrogated induction of mitochondrially encoded genes 
(Figure A.S1F), which suggests that a NAD
+
-dependent pathway is necessary for their 
induction. These data indicate that a NAD
+
-dependent pathway, possibly via a sirtuin, 
mediates induction of mitochondrially encoded genes in the fasted response. SIRT3 
protein is a sensor of nutrient deprivation that is induced in fasted liver mitochondria 
(234, 261). Moreover, prior studies in cell lines indicate that it influences cellular 
respiration (236-238); thus, SIRT3 might coordinate changes in energy metabolism with 
the fasted response. For these reasons, SIRT3 protein was an attractive candidate in the 
control of mitochondrially encoded gene expression and concomitant OXPHOS in fasted 
liver. We therefore challenged Sirt3 KO primary hepatocytes with glucagon. Similar to 
nicotinamide-treated primary hepatocytes, glucagon stimulated several fasting-responsive 
genes in the Sirt3 KO primary hepatocytes, but failed to induce mitochondrially encoded 
gene expression or mitochondrially encoded translation products (Figure A.3D–H).  
Given that SIRT3 is implicated in energy metabolism in cell lines and is induced 
in fasted liver, we evaluated the fasting response in Sirt3 KO mouse liver. Neither 
mitochondrially encoded transcripts nor OXPHOS were induced in fasted Sirt3 KO liver, 
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despite a slight increase in mitochondrial content (Figure A.4A–F). Again, there was no 
change in nuclear encoded ETC subunits (Figure A.S3). Additionally, we depleted SIRT3 
in C57BL/6 mouse liver using shRNA targeting Sirt3 (Figure A.S4A). Again, both 
mitochondrially encoded gene expression and induction of OXPHOS were impaired, 
independent of mitochondrial content (Figure A.S4). Moreover, SIRT3 knockdown did 
not influence the general fasting response, as these mice proved indistinguishable from 
wild-type C57BL/6 mice (compare Figure A.1B and Figure A.S4D). These findings in 2 
mouse models of SIRT3 deficiency argue that SIRT3 is required for induction of 
mitochondrially encoded transcripts and OXPHOS in fasted liver.  
Next, we evaluated whether SIRT3 is sufficient to induce mitochondrially 
encoded gene expression. SIRT3 was ectopically expressed in mouse liver using 
adenovirus encoding Sirt3 (Figure A.S5A–E). To minimize hormonal influences and 
genetic variations due to feeding status, food was briefly removed for 3 hours to clear the 
gastrointestinal tract of residual food. Brief food deprivation did not alter mitochondrially 
encoded transcripts or SIRT3 protein (data not shown), the latter of which is induced only 
after a longer fast (234). Even in the absence of potent fasting cues, ectopic expression of 
SIRT3 modestly induced mitochondrially encoded gene expression.  
Induction of mitochondrially encoded genes was not associated with alterations in 
mitochondrial content (Figure A.S5D and E). This action proved cell autonomous, as 
mitochondrially encoded gene expression was also induced in H2.35 murine hepatoma 
cells stably expressing SIRT3 as well as in primary hepatocytes transduced for 36 hours 
with Sirt3 adenovirus (Figure A.4G–L, and Figure A.S5F and G). Unlike primary  
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Figure A.4. In liver, SIRT3 is necessary and sufficient for fasting-mediated 
induction of mitochondrial encoded transcripts and OXPHOS. (A) Hepatic gene 
expression of mitochondrially encoded transcripts in 24-hour fasted Sirt3 KO mice (129S 
background) (n=3). (B) Expression of genes that regulate mitochondrial biogenesis, 
mitochondrial transcription, lipogenesis, and gluconeogenesis in Sirt3 KO liver (n=3). 
(C) Complex activity from liver of 24-hour fasted or fed Sirt3 KO mice (n=3). (D) 
Genetic assessment of mitochondrial content using mtDNA content (n=3). (E) 
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Biochemical assessment of mitochondrial content using citrate synthase activity in whole 
liver homogenate (n = 3). (F) Assessment of mitochondrial content by immunoblotting 
citrate synthase protein in whole liver homogenate (n=3). (G and H) Expression of (G) 
mitochondrially encoded transcripts and (H) genes that regulate mitochondrial biogenesis 
and mitochondrial transcription in H2.35 hepatoma cells stably expressing LacZ or 
SIRT3 (n=3). (I) Immunoblot showing expression of ectopically expressed myc-tagged 
SIRT3 protein. (J) Using a Clark-type oxygen electrode, cellular respiration — basal, 
proton leak, and maximal respiration (FCCP) — was assessed in H2.35 hepatoma cells 
stably expressing LacZ or SIRT3. (n=4). See Figure A.S6 for representative oxygen 
consumption curves. (K) Fluorescent assessment of mitochondrial content using 
MitoTracker Green FM (n=3). (L) Genetic assessment of mitochondrial content using 
mtDNA content (n=3). Data are mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, 2-
way ANOVA, with (A and G) or without (B and H) Bonferroni post-test, or 2-tailed 
unpaired Student’s t test (C–E and J–L).  
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hepatocytes, H2.35 hepatoma cells stably transduced with SIRT3 required 
supplementation with 500 μM NAD+, a cofactor for SIRT3. Even though mechanisms 
involving NAD
+
 uptake by mitochondria remain controversial, extracellular NAD
+
 does 
increase the concentration of NAD
+
 within mitochondria (262, 263). To make fair 
comparisons, LacZ H2.35 control cells were treated likewise.  
Next, we evaluated OXPHOS in H2.35 cells stably expressing SIRT3. In cells 
replete with SIRT3, maximal cellular respiration was modestly induced about 12%, while 
basal respiration and proton leak were unchanged (Figure A.4J). Increased respiratory 
capacity was independent of de novo mitochondrial biogenesis (Figure A.4K and L). 
Using galactose, a fuel in which very little ATP is derived from glycolysis, maximal 
cellular respiration was increased about 37% (Figure A.S6). These data imply that, after a 
bout of fasting, induction of SIRT3 is both necessary and sufficient for the induction of 
mitochondrially encoded transcripts and OXPHOS.  
 
SIRT3 activates mitochondrial transcription and promotes OXPHOS via LRP130 
Induction of mitochondrially encoded transcripts stimulates OXPHOS (12). 
Mitochondrially encoded gene expression is the summation of transcription and 
degradation. Presumably, SIRT3 influenced one or both of these pathways. Transcription 
and RNA degradation can be assessed by metabolic labeling, using pulse and pulse-chase 
experiments, respectively (Figure A.5A). To assess mitochondrial transcription, we 
pulse-labeled cells with 4-thiouridine (4sU), a naturally occurring analog of UTP. After 
isolating RNA, 4sU-labeled transcripts were biotinylated, recovered on streptavidin  
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Figure A.5. SIRT3 induces mitochondrially encoded genes by stimulating 
mitochondrial transcription. (A) Metabolic labeling with 4sU. This method quantifies 
de novo transcripts, permitting assessment of mitochondrial transcription in whole cells. 
It can also be used to monitor transcript degradation. (B) Transcription of Sirt3, driven by 
the viral CMV promoter, was induced in cells replete with SIRT3, whereas transcription 
of several housekeeping genes was unchanged (n=3). (C) Cells stably expressing SIRT3 
exhibited increased mitochondrial transcription (n=3). (D) Uridine was used to chase the 
4sU label and assess transcript half-life. Half-lives of mitochondrial transcripts in H2.35 
hepatoma cells stably expressing SIRT3 were unchanged. Data are mean ± SEM. ****P 
< 0.0001, 2-way ANOVA, with (B) or without (C) Bonferroni post-test. 
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beads, and quantified by quantitative PCR (qPCR). Because labeling is brief and much 
shorter than the half-life of most mitochondrially encoded transcripts, this method allows 
for quantitative assessment of transcription (253, 264, 265). Driven by a powerful CMV 
promoter, Sirt3 mRNA served as a positive control for transcription (Figure A.5B). 
Several housekeeping genes were unchanged (Figure A.5B), indicative of specific 
transcription. Ectopic expression of SIRT3 induced mitochondrial transcription, but 
failed to influence transcript degradation (Figure A.5C and D). Akin to transcription in 
the nucleus, these data support the general observation that changes in gene expression 
are largely driven by transcription (264). Overall, these data indicate that SIRT3 induces 
mitochondrially encoded gene expression by stimulating mitochondrial transcription. 
Given that mitochondrial mass and mtDNA content were stable (Figure A.4 and Figure 
A.S5), induction by SIRT3 signified increased transcription per mitochondrial genome.  
Next, we explored the mechanism by which SIRT3 influences mitochondrial 
transcription and OXPHOS. Independent of de novo mitochondrial biogenesis, it was 
previously reported that LRP130 interacts with POLRMT, culminating in enhanced 
mitochondrial transcription and attendant OXPHOS (126). We therefore wondered 
whether SIRT3 activates mitochondrial transcription and OXPHOS via LRP130. To test 
this, we ectopically expressed SIRT3 in cells deficient for LRP130. Using a previously 
validated RNAi (123, 126, 160), LRP130 knockdown in H2.35 cells was greater than 
85% at the mRNA and protein levels (Figure A.6A and B). As previously reported (123, 
126, 160), mitochondrially encoded transcripts were globally attenuated in LRP130-
deficient cells, whereas genes involved in mitochondrial biogenesis and mitochondrial  
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Figure A.6. SIRT3-mediated induction of mitochondrial transcription requires 
LRP130. (A–D) Gene expression of Lrp130 and Sirt3 (A), representative immunoblot of 
LRP130 and SIRT3 (B), gene expression of mitochondrially encoded transcripts (C), and 
expression of genes that regulate mitochondrial biogenesis and mitochondrial 
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transcription (D) in H2.35 hepatoma cells replete with LacZ or SIRT3, superimposed 
with control (shCtrl) or Lrp130 knockdown (shLRP130) (n=3). (E–G) H2.35 hepatoma 
cells replete with SIRT3 or LacZ, but deficient for LRP130, were used. (E) SIRT3 was no 
longer sufficient to influence maximal respiration, using a Clark-type oxygen electrode (n 
= 6). However, control shRNA SIRT3 cells retained increased respiratory capacity (see 
Figure A.S6). Assessment of mitochondrial content was unchanged, as assessed by (F) 
MitoTracker Green FM or (G) mtDNA content (n=3). (H–K) LRP130 liver-specific 
knockout (LRP130 LKO) mice were used. Hepatic gene (H) and protein (I) expression 
(n=4). (J) Effect of fasting on mitochondrially encoded genes in liver. (K) Effect of 
fasting on fasting-responsive genes in liver. Data are mean ± SEM. *P < 0.05, **P < 
0.01, ***P < 0.001, 2-way ANOVA, with (A, D, H, and K) or without (C and J) 
Bonferroni post-test, or 2-tailed unpaired Student’s t test (E–G).  
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transcription were unchanged (Figure A.6C and D). In cells deficient for LRP130, 
ectopically expressed SIRT3 failed to induce either mitochondrially encoded transcripts 
or OXPHOS (Figure A.6C and E). In contrast, OXPHOS was increased in control shRNA 
LacZ cells replete with SIRT3 protein (Figure A.S6), an induction similar to that shown 
in Figure A.4J. Effects on mitochondrial transcription and energy metabolism were not 
caused by altered mitochondrial content, as genetic and fluorescent markers of 
mitochondrial content were unperturbed (Figure A.6F and G). Finally, effects on 
mitochondrial transcription and energy metabolism were not caused by perturbation of 
TFB2M or POLRMT, which collectively comprise the basal transcription machinery. 
Specifically, cells deficient or replete with LRP130 protein did not alter POLRMT or 
TFB2M protein levels (Figure A.S7A and B).  
Next, we fasted mice in which Lrp130 was ablated in liver. To achieve liver-
specific deletion of Lrp130 in adult mice, animals harboring floxed Lrp130 alleles were 
injected via tail vein with adeno-associated virus containing a vector coding for liver-
specific cre recombinase (AAV-Cre), yielding liver-specific LRP130 KO mice (referred 
to herein as LRP130 LKO mice; Figure A.6H and I). After a 24-hour fast, 
mitochondrially encoded genes were induced in wild-type mice, but not LRP130 LKO 
mice (Figure A.6J), which indicates that LRP130 is required for induction of 
mitochondrially encoded genes in fasted liver. As previously reported, mitochondrially 
encoded gene expression was globally decreased in LRP130 LKO liver (Figure A.6J). 
Details of the Lrp130
flox/flox
 allele are shown in Figure A.S7C. We additionally ectopically 
expressed SIRT3 in Lrp130 KO primary hepatocytes. The ability of SIRT3 to induce 
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mitochondrially encoded genes was abrogated in Lrp130 KO hepatocytes (Figure A.S8). 
Finally, we evaluated fatty acid in H2.35 cells stably expressing SIRT3 but deficient for 
LRP130, since fatty acid oxidation depends on OXPHOS. Antimycin A (which inhibits 
electron transfer and, hence, OXPHOS) served as a positive control. In the absence of 
LRP130, fatty acid oxidation was significantly impaired (Figure A.S8), which suggests 
that LRP130 is required for fatty acid oxidation. In summary, SIRT3 activated 
mitochondrial transcription and increased OXPHOS. This action was dependent on 
LRP130, a regulator of mitochondrial transcription and OXPHOS.  
 
SIRT3 deacetylates LRP130 in fasted liver and increases its transcriptional activity 
Given that nutrient deprivation induces mitochondrial SIRT3, we evaluated 
whether SIRT3 influences acetylation of LRP130 protein in fasted liver mitochondria. 
Compared with fed liver, LRP130 was deacetylated in fasted liver mitochondria, a state 
in which SIRT3 activity (and protein) was increased (Figure A.7A). Supporting 
regulation by SIRT3, LRP130 was hyperacetylated in SIRT3-deficient mouse liver 
(Figure A.7B). In accordance with cell-autonomous control, NAD
+
 promoted 
deacetylation of LRP130 in H2.35 cells replete with SIRT3 (Figure A.7C). Buttressing 
these data, LRP130 coimmunoprecipitated with SIRT3 (Figure A.7D), but failed to 
immunoprecipitate with SIRT5 (data not shown), another — albeit less potent — 
deacetylase localized to mitochondria. To assess a functional interaction, we evaluated 
whether SIRT3 deacetylates purified LRP130 protein. Since mitochondrial acetylases 
have not been characterized, we used CREB-binding protein (CBP) to acetylate purified  
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Figure A.7. During the fasted response, SIRT3 deacetylates LRP130 in liver 
mitochondria. (A) Representative immunoblot and protein quantification showing 
reduced acetylation of LRP130 (Ac-LRP130) in mitochondria isolated from fasted mouse 
liver (n=3 experiments). (B) Immunoblot and protein quantification showing 
hyperacetylation of LRP130 in mitochondria isolated from liver deficient for SIRT3 (n = 
4). (C) Immunoblot showing deacetylation of LRP130 in H2.35 cells stably expressing 
SIRT3 upon treatment with 500 μM NAD+. (D) SIRT3 and LRP130 
coimmunoprecipitated, using ectopically expressed SIRT3-FLAG protein and 
endogenous LRP130. (E) Using purified proteins, SIRT3 robustly deacetylated the C 
terminus of LRP130. Deacetylation of LRP130 was inhibited by 12.5 mM nicotinamide 
(NAM). Shown is 1 representative of 4 independent experiments. Similar, but less robust, 
deacetylation was obtained for the N terminus of LRP130 (not shown). (F) Acetylated 
LRP130 fragments were incubated with control buffer or purified SIRT3 protein, then 
subjected to mass spectrometry. Lysines showing greater than 50% deacetylation by 
SIRT3 are graphed (gray and black bars). Percent deacetylation was calculated as 1 – 
(SIRT3 signal/control signal). 7 lysines were mutated to arginines (gray bars), generating 
LRP130-7KR, which mimics deacetylated protein. Data are mean ± SEM. *P < 0.05, **P 
< 0.01, ***P < 0.001, 2-tailed unpaired Student’s t test (A and B).   
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LRP130 protein, an approach that is standard in the field (266, 267). In the presence of 
purified SIRT3 protein, acetylated LRP130 C-terminal protein was robustly deacetylated 
by SIRT3 (Figure A.7E). Similar, but less robust, results were obtained using N-terminal 
fragments of LRP130 (data not shown). Collectively, these data argue that SIRT3 
deacetylates LRP130 in fasted liver. Finally, the conclusion that LRP130 is a bona fide 
target of SIRT3 was buttressed by a review of proteomic analyses (268-270), in which 
SIRT3 was found to be deficient in either cells or mouse liver (Figure A.S9).  
Next, we used mass spectrometry to map 17 lysine residues of LRP130 sensitive 
to deacetylation by SIRT3 (Figure A.7F and Table A.S1). Sites with greater than 2-fold 
change were deemed positive. The mass spectrometry signal from the control reaction 
containing acetylated LRP130 protein was divided into the signal from the SIRT3 
reaction. This ratio was subtracted from 1, yielding the arbitrary metric of percent 
deacetylation.  
To evaluate the genetic and functional implications of LRP130 protein 
acetylation, we mutated 7 of 17 acetylated lysines to arginine (referred to herein as 
LRP130-7KR; Figure A.7F and Table A.S1). By mutating a lysine to an arginine, a 
mutated site retains its positive charge and functionally mimics deacetylated protein. 
Similarly, we generated a 7KQ mutant of LRP130 (LRP130-7KQ). Mutating a lysine to 
glutamine retains a neutral charge at the site and often mimics acetylated protein. 2 
groups previously reported that LRP130 stimulates mitochondrial transcription (126, 
271). In cell lysates, LRP130 interacted with both TFB2M and POLRMT (126), both of 
which comprise the basal transcription machinery of mitochondria (243). We therefore 
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reasoned that the acetylation status of LRP130 might influence its interaction with 
TFB2M and/or POLRMT. Because POLRMT and LRP130 migrate at similar molecular 
weights, we refined the level of interaction to aas 340–710 of POLRMT (Figure A.S10). 
This enabled us to use a 1–710 aa fragment of POLRMT, which is easily distinguished 
from LRP130. We evaluated whether LRP130-7KR (which mimics deacetylated protein) 
differentially interacts with either TFB2M or the 1–710 aa fragment of POLRMT. 
Compared with murine LRP130-WT, LRP130-7KR preferentially interacted with 
POLRMT, whereas differential binding of TFB2M was less apparent (Figure A.8A and 
B).  
Next, we evaluated whether LRP130-7KR and LRP130-7KQ exhibited 
differential activity. We transiently expressed LRP130-WT or the murine LRP130 
mutants in 293T cells deficient for endogenous human LRP130. We used this strategy to 
mitigate competition with endogenous LRP130 and to evaluate activity using 
physiologically relevant levels of LRP130 protein. Although human and mouse LRP130 
share more than 75% homology at the protein level, the shRNA targeting human LRP130 
mRNA does not target mouse Lrp130 mRNA. Knockdown of human LRP130 in 293T 
cells and reconstitution with murine LRP130 is shown in Figures A.S11 and A.S12. 
Endogenous SIRT3 activity was inhibited using 10 mM nicotinamide, a dose previously 
shown to impair NAD
+
-dependent sirtuin activity in 293T cells. Compared with LRP130-
WT, LRP130-7KR exhibited greater activity, as assessed by mitochondrial gene 
expression, mitochondrial transcription, and oxygen consumption (Figure A.8C, D, and 
F). The level of ectopically expressed LRP130 protein was comparable (Figure A.8E).  
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Figure A.8. LRP130-7KR stimulates mitochondrial transcription and promotes 
OXPHOS. (A) LRP130-7KR, which mimics deacetylated protein, showed increased 
affinity for aas 1–710 of POLRMT, a fragment that contains the catalytic domain. See 
Figure A.S10 for more detailed mapping. (B) In contrast, compared with LRP130-WT, 
LRP130-7KR showed no differential affinity for TFB2M. (C, D, and F) Using 293T 
cells, endogenous human LRP130 was knocked down >95%, then reconstituted with 
murine LRP130-WT or LRP130-7KR (see Figure A.S11). The shRNA targeting human 
LRP130 does not target mouse Lrp130 (not shown). Endogenous NAD
+
-dependent 
sirtuin activity was inhibited with 10 mM nicotinamide for 16 hours. LRP130-7KR had 
greater (C) mitochondrially encoded gene expression (n=3), (D) mitochondrial 
transcription (n=3), and (F) maximal respiration (n=5) versus LRP130-WT. (E) 
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Immunoblot showing similar levels of ectopically expressed LRP130-WT and LRP130-
7KR. See Figure A.S11 for total LRP130 protein. Data are mean ± SEM. *P < 0.05, ***P 
< 0.001, 2-way ANOVA (C and D) or 2-tailed unpaired Student’s t test (F).  
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Interestingly, the effect on transcription was much greater than that on respiration, 
indicative of either a saturation effect or limitations of our experimental system. In 
contrast, LRP130-7KQ did not increase mitochondrially encoded gene expression (Figure 
A.S12), which suggests that deacetylation of LRP130 (as reflected by LRP130-7KR) 
increases its activity. Since SIRT3-dependent pathways were inhibited by nicotinamide, 
in terms of mitochondrial transcription and OXPHOS, these data indicate that LRP130 is 
a crucial mediator of SIRT3 action. Taken together, our results imply that deacetylation 
of LRP130 by SIRT3 enhances the activity of LRP130, which in turn stimulates 
mitochondrial transcription and OXPHOS.  
In summary, we have identified a mechanism whereby nutrient sensing by SIRT3 
induces mitochondrial transcription and enhances OXPHOS via LRP130 (Figure A.9). 
Moreover, our present findings indicate that SIRT3 coordinates activation of enzyme 
systems involved in fatty acid oxidation as well as OXPHOS. In fasted liver, our data 
support a model whereby activation of mitochondrial transcription increases OXPHOS 
capacity, and this enhanced bioenergetic efficiency would be predicted to support 
increased substrate oxidation.  
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Figure A.9. In fasted liver, the transcription machinery of mitochondria sense 
nutrient deprivation via SIRT3, culminating in enhanced energy metabolism. In 
liver, SIRT3 is induced by nutrient deprivation. Specifically, glucagon, which activates 
cAMP signaling, increases SIRT3 activity, perhaps by indirectly increasing 
mitochondrial NAD
+
 levels. LRP130 is then deacetylated and activated by SIRT3, which 
strengthens the LRP130-POLRMT interaction. This culminates in increased 
mitochondrial transcription and attendant OXPHOS. Presumably, processes dependent on 
OXPHOS — fatty acid oxidation, gluconeogenesis, ketogenesis, and ureagenesis — are 
augmented by increased respiratory capacity. To simplify the model, deacetylation of 
enzymes involved in fatty acid oxidation and ketogenesis, as well as SIRT3 action on 
individual OXPHOS subunits, are not illustrated.  
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Discussion 
Here, we identified an unanticipated link between nutrient sensing and 
mitochondrial transcription that was critical for fasting-mediated induction of OXPHOS. 
In fasted liver, ATP synthesis is accompanied by a 20% increase in oxygen consumption 
(272, 273), enabling ATP-dependent processes such as gluconeogenesis and ureagenesis. 
While increases in nutrient flux and oxidation are essential, OXPHOS capacity is critical 
factor as well. We showed here that SIRT3 deacetylated LRP130 during the fasted 
response. Once deacetylated, LRP130 stimulated mitochondrial transcription to increase 
mitochondrially encoded gene expression and OPXHOS, independent of de novo 
mitochondrial biogenesis. In fasted liver, SIRT3 protein has previously been shown to 
plateau at 18–24 hours and activate enzyme systems involved in fatty acid oxidation, 
culminating in greater β-oxidation of fatty acids (234). At 24 hours, we observed SIRT3-
mediated deacetylation of LRP130. We therefore propose that SIRT3 couples enhanced 
β-oxidation of fatty acids to increase OXPHOS capacity via LRP130. Presumably, this 
strategy permits metabolic matching between 2 enzyme systems that are linked by 
coenzyme cycling: shuttling of NAD
+
 and NADH between fatty oxidative pathways and 
OXPHOS.  
Governed by SIRT3 and LRP130, nutrient control of OXPHOS via mitochondrial 
transcription is a simple, yet elegant, model. Regarding control of OXPHOS, prior studies 
on SIRT3 implicated modifications of various subunits of the electron transport chain or 
alterations in mitochondrial content. In SIRT3-deficient cell lines, respiration is impaired 
and there is hyperacetylation of several respiratory complexes, including complex I (236, 
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239), succinate dehydrogenase (238), and complexes III and V (239). The stabilization of 
several nuclear encoded subunits may be related to their acetylation status, which might 
explain the differential regulation of complex activity previously reported by others 
(236). One limitation to interpreting these studies is that mutant subunits that mimic 
acetylated or deacetylated protein were not evaluated. It is therefore difficult to discern 
the functional relevance of these modifications.  
In liver, the salutary actions of SIRT3 on OXPHOS do not require an increase in 
mitochondrial content. This is in contrast to immortalized, brown fat–like HIB1B cells, in 
which ectopic expression of SIRT3 was associated with increased Pgc1a, mitochondrial 
biogenesis, and concomitant OXPHOS (186). Using mouse models and cell culture, we 
did not observe changes in mitochondrial mass due to SIRT3, which suggests that the 
effect of SIRT3 on mitochondrial mass is restricted to certain cellular contexts. Notably, 
our results indicate a prominent role for SIRT3 in mitochondrial transcription, which 
promotes OXPHOS. Ectopic expression of SIRT3 in cells deficient for LRP130 protein 
failed to induce OXPHOS or mitochondrially encoded genes. Similarly, in liver deficient 
for LRP130, fasting failed to induce mitochondrially encoded gene expression. These 
data suggest that mechanisms independent of LRP130 are either trivial or operate 
downstream of mitochondrial transcription. For instance, in LRP130-deficient cells, 
reduction of mitochondrially encoded genes is associated with reduced OXPHOS 
subunits (123, 126, 133, 160), attenuation that might offset deacetylation of individual 
OXPHOS subunits. If normal mitochondrially encoded gene expression is a prerequisite 
for SIRT3-mediated activation of individual OXPHOS subunits, then ablation of LRP130 
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would abrogate any downstream effect. Additionally, LRP130 might influence factors 
involved in mitochondrial transcription. In our studies, neither POLRMT nor TFB2M, 
which comprise the initiation complex, were unchanged. Even so, we cannot exclude the 
possibility that other factors involved in transcription are not secondarily perturbed. 
Nevertheless, LRP130-deficient cells still retained some OXPHOS complexes, albeit less 
than those of wild-type cells. If activation of individual OXPHOS subunits were a 
predominant action of SIRT3, one would anticipate some enhancement of OXPHOS even 
in the absence of LRP130, a finding we failed to observe. Additionally, SIRT3 regulates 
several hundred mitochondrial proteins. Indeed, in other cellular systems, variegated 
actions of SIRT3 are not readily intuitive (274); hence, without further investigation, our 
findings predominantly relate to the fasted response. Nonetheless, even when NAD
+
-
dependent sirtuins were pharmacologically inhibited, LRP130-7KR had greater activity 
in terms of transcription and OXPHOS capacity. This indicates that isolated deacetylation 
of LRP130 is sufficient to stimulate mitochondrial transcription and OXPHOS. Although 
we cannot exclude direct effects of acetylation on OXPHOS complexes per se, our data 
highlight a significant pathway involving mitochondrial transcription and attendant 
OXPHOS mediated by SIRT3 and LRP130.  
Our results indicate that SIRT3 influences mitochondrial transcription via 
LRP130. In concert with prior reports by us and others (126, 271), these data further 
support a role for LRP130 in the control of mitochondrial transcription. Some studies 
have reported that LRP130 stabilizes mitochondrial transcripts; however, such a role for 
LRP130 in SIRT3-mediated control of mitochondrial gene expression was not supported 
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here. As stated earlier, the LRP130-7KR mutant increased mitochondrially encoded 
transcripts, even when endogenous SIRT3 was inhibited. This suggests that deacetylation 
of basal mitochondrial transcription is not strictly required. Thus far, no differential 
acetylation has been reported for POLRMT or TFB2M, which collectively constitute the 
initiation complex. While our results suggest that deacetylation of LRP130 is sufficient to 
stimulate mitochondrial transcription and attendant OXPHOS, we cannot definitely 
exclude parallel deacetylation and activation of the basal transcription machinery. TFAM, 
a regulator of both mitochondrial transcription and replication, is acetylated in cells and 
mouse liver (269, 275), which is dependent on SIRT3 (269). After caloric restriction, 
there is a slight decrease in acetylation of TFAM; however, the functional and biological 
significance of this slight change is unknown, as an acetylation mutant was not evaluated 
(269). Although interesting and important, evaluating the basal transcription machinery in 
the context of biology will prove challenging, since ablation of its components 
completely interdicts OXPHOS, while in our study, ectopic expression of either TFB2M 
or POLRMT paradoxically attenuated mitochondrially encoded gene expression. This 
implies a finely tuned balance, limiting the tools and approaches available to decipher 
mechanisms. In terms of mitochondrially encoded gene expression, ablation of LRP130 
still permitted some basal transcription, while its ectopic expression induced 
transcription. We therefore believe LRP130 is uniquely poised to specifically evaluate 
mitochondrial transcription and OXPHOS.  
What are the broader questions pertinent to integrative physiology and disease? 
An increasing number of reports suggest that a mismatch between nutrient flux and 
135 
 
oxidative capacity promotes and/or exacerbates insulin resistance (230-232). In human 
and mouse studies, increased fatty acid flux in the setting of impaired tricarboxylic acid 
and/or OXPHOS activity is associated with insulin resistance (230, 232, 276, 277). 
SIRT3 activity is impaired in mice fed a high-fat diet for 16–24 weeks that develop 
insulin resistance (278). Additionally, ablation of SIRT3 leads to metabolic syndrome 
(239, 240), suggestive of a causal role. Although the notion is speculative, a decline in 
SIRT3 activity might lead to impaired OXPHOS in liver and exacerbate insulin 
resistance. One additional question to consider is whether pathways involved in 
OXPHOS and fatty acid oxidation exhibit differential sensitivity to SIRT3 activity, which 
might produce a mismatch between fatty acid oxidation and OXPHOS.  
In conclusion, induction of SIRT3 by fasting induced OXPHOS by increasing 
mitochondrial gene expression. Upon deacetylation by SIRT3, LRP130 induced 
mitochondrial transcription, culminating in greater OXPHOS capacity. We hypothesize 
that greater OXPHOS capacity improves mitochondrial bioenergetic efficiency, thereby 
supporting parallel and downstream biochemical pathways. 
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Figure A.S1. cAMP signaling mediates induction of mitochondrially encoded genes, 
Pgc-1α is not required for induction of mitochondrially encoded gene expression but 
NAD
+
-dependent pathways are required. A) Following an 18 hour treatment with 
forskolin, which increases intra-cellular cAMP levels, Pepck and G6p, both of which are 
fasting responsive genes, were induced in primary hepatocytes. B) Treatment of primary 
hepatocytes with forskolin also induced mitochondrially encoded gene expression. C) In 
Pgc-1α null hepatocytes, glucagon induces fasting responsive genes similar to wild-type 
A B 
C D 
E F 
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cells. D) In Pgc-1α null hepatocytes, glucagon still induces mitochondrially encoded gene 
expression; but, the induction is modestly blunted. Note: induction of mitochondrially 
encoded gene expression by forskolin was normal in primary hepatocytes in which Pgc-
1α was knocked down more than 75% (data not shown). E) Nicotinamide (NAM; an 
inhibitor of NAD
+
)-dependent pathways did not alter glucagon mediated induction of 
fasting responsive genes; however, F) induction of mitochondrially encoded gene 
expression was completely abrogated (n=3). 2-way ANOVA for all studies. For nuclear 
encoded genes, a Bonferroni post test was also performed. *p<0.05, **p<0.01, 
***p<0.001 (n=3). 
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Figure A.S2. Fasting induces mitochondrially encoded genes in 129S mice. (A) 
Hepatic gene expression of mitochondrially encoded transcripts in 129S mice fasted for 
24 hours (n=5). (B) Expression of genes that regulate mitochondrial biogenesis, 
mitochondrial transcription, lipogenesis and gluconeogenesis (n=5). (C) Expression of 
several nuclear encoded ETC genes. (D) Genetic assessment of mitochondrial content 
using mitochondrial DNA content (n=5). (E) Biochemical assessment of mitochondrial 
content using citrate synthase (CS) activity in whole liver homogenate (n=5). (F) 
Assessment of mitochondrial content using citrate synthase (CS) protein in whole liver 
homogenate (n=5). For gene expression, 2-way ANOVA with Bonferroni post test where 
indicated. (mean+s.e.m, *p<0.05, **p<0.01, ***p<0.001). 
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Figure A.S3. Effect of fasting in Sirtuin 3 knockout mouse liver (S3KO) on a 129S 
mice background. Gene expression of several nuclear encoded mitochondrially encoded 
genes in sirtuin 3 knockout mouse liver (S3KO) in the fed or fasted state (n=3). For gene 
expression, 2-way ANOVA with Bonferroni post test (p=ns for all comparisons). Error 
bars represent mean±s.e.m. 
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Figure A.S4. In liver, knockdown of Sirt3 in C57BL6 mouse liver impairs fasting-
mediated induction of mitochondrially encoded genes and OXPHOS. (A) Protein 
expression in Sirt3 deficient mouse liver. Sirt3 knockdown was achieved by tail vein 
injecting adenovirus encoding shSirt3. Knockdown of SIRT3 protein in liver was 
confirmed by comparison with a control shRNA (shCtrl) (n=4). (B) Gene expression of 
Sirt3 following its knockdown in mouse liver (n=3). (C) Hepatic gene expression of 
mitochondrially encoded transcripts in liver deficient for SIRT3. Mice were either in the 
fed state or fasted for 24 hours (n=3). (D) Expression of genes that regulate mitochondrial 
biogenesis, mitochondrial transcription, lipogenesis and gluconeogenesis in liver 
deficient for SIRT3 (n=3). (E) Complex activity of mitochondria isolated from shSirt3 
mouse liver either in the fed state or after fasting for 24 hours (n=3). CI through CV 
denotes activities for complexes I through V. CS denotes citrate synthase . (F) 
Biochemical assessment of mitochondrial content using citrate synthase activity in whole 
liver homogenate (n=3). (G) Genetic assessment of mitochondrial content using 
mitochondrial DNA content (n=3). (H) Citrate synthase (CS) immunoblot. (I) Gene 
expression of several nuclear encoded electron transport chain subunits (n=3). For gene 
expression, 2-way ANOVA with Bonferroni post test where indicated. For complex 
activity and mitochondrial content, 2-tailed unpaired Student’s t test. (mean+s.e.m, 
*p<0.05, **p<0.01, ***p<0.001) 
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Figure A.S5. Ectopic expression of SIRT3 in mouse liver and primary hepatocytes 
induces mitochondrially encoded transcripts. (A) Hepatic gene expression of 
mitochondrially encoded transcripts in mouse liver transduced with adenovirus encoding 
either GFP or Sirt3 (n=4). (B) Expression of genes that influence mitochondrial 
biogenesis and mitochondrial transcription (n=4). (C) Immunoblot showing expression of 
ectopically expressed myc-tagged SIRT3 protein, following transduction of C57BL6 
mouse liver with adenovirus. Note, ectopically expressed SIRT3 is myc-tagged, and thus, 
migrates at a slightly higher molecular weight. (D) Biochemical assessment of 
mitochondrial content using citrate synthase activity of whole liver homogenate (n=4). (E) 
Genetic assessment of mitochondrial content using mitochondrial DNA content (n=3). (F) 
Gene expression of mitochondrially encoded transcripts in primary hepatocytes 
transduced with adenovirus encoding either GFP or Sirt3 (n=3). (G) Expression of genes 
that influence mitochondrial biogenesis and mitochondrial transcription in primary 
hepatocytes (n=3). (H) Immunoblot showing expression of ectopically expressed myc-
tagged SIRT3 protein in primary hepatocytes. For gene expression, 2-way ANOVA with 
Bonferroni post test where indicated. For mitochondrial content, 2-tailed unpaired 
Student’s t test. (mean+s.e.m, ***p<0.001). 
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Figure A.S6. Respiration and mitochondrial content in H2.35 hepatoma cells with 
ectopic expression of Sirt3. (A) Cellular respiration in shControl H2.35 hepatoma cells 
replete with sirtuin 3 (Sirt3). 2-tailed unpaired Student’s t test. (n=3-4, mean±std, *p < 
0.05). (B) MitoTracker Green, a measure of mitochondrial biogenesis, was assessed in 
H2.35 hepatoma cells replete with sirtuin 3 (Sirt3) that co-express shControl RNA 
(shCtrl). (n=3, mean±s.e.m.). (C) Mitochondrial DNA content, a measure of 
mitochondrial content, was quantified in H2.35 hepatoma cells replete with sirtuin 3 
(Sirt3) that co-express shControl RNA (shCtrl). 2-tailed unpaired Student’s t test. 
(mean±s.e.m, *p<0.05). Representative oxygen consumption curves for (D) H2.35 
heptoma cells expressing LacZ or Sirt3 as shown in Figure 3J and (E) those that co-
express shControl RNA (shCtrl) as shown here in Fig. S6A. (F) Cellular respiration using 
galactose in H2.35 hepatoma cells that ectopically express LacZ or sirtuin 3 (Sirt3). 2-
tailed unpaired Student’s t test. (n=3-4, mean±std, *p < 0.05). Two hours prior to cell 
collection, medium was changed to galactose containing medium. Respiration was 
performed as described in materials and methods but galactose was used in in lieu of 
glucose. (G) Representative oxygen consumption curves for galactose respiration studies. 
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Figure A.S7. Effect of LRP130 protein level on the basal transcription machinery 
and a schematic of the LRP130 floxed allele. (A) Immunoblot of mitochondria isolated 
from H2.35 hepatoma cells, showing that deficiency of LRP130 does not alter the level of 
POLRMT or TFB2M protein. (B) Immunoblot of mitochondria isolated from H2.35 
hepatoma cells, showing that ectopic expression of LRP130 does not alter the level of 
POLRMT or TFB2M protein. (C) Schematic of the floxed allele in LRP130 flox/flox 
(F/F) mice. To generate LRP130 liver-specific KO mice (LRP130 LKO), liver specific 
adeno-associated virus that expresses Cre recombinase (AAV-Cre) was tail vein injected 
into adult male LRP130 flox/flox mice of 8-12 weeks of age. Littermate control male 
wild-type mice were also injected with AAV-Cre.1 x 10(11) GC viral particles were tail 
vein injected per mouse. After 3 weeks, liver was harvested in either the fed or fasted 
state (Fig. 5H-K). 
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Figure A.S8: Effect of ectopic expression of SIRT3 in LRP130 deficient cells. (A) 
Immunoblot showing expression of ectopically expressed myc-tagged SIRT3 protein in 
LRP130 KO hepatocytes. (B) Gene expression of mitochondrially encoded transcripts in 
LRP130 KO hepatocytes transduced with adenovirus encoding either GFP or Sirt3 (n=4). 
Note, in LRP130 KO hepatocytes, SIRT3 is no longer sufficient to induce 
mitochondrially encoded genes. (C) Expression of genes that influence mitochondrial 
biogenesis and mitochondrial transcription (n=4). D, Fatty acid oxidation of radiolabeled 
14C-palmitate to CO2 in H2.35 cells stably expressing sirtuin 3 and treated with NAD
+
 
as describe in the methods section. Deficiency of LRP130 was associated with reduced 
fatty acid oxidation. Antimycin A, which inhibits the electron transport chain at complex 
III, serves as a positive control, showing nearly complete inhibition of fatty acid 
oxidation (n=3). In cells treated with nicotinamide there was no longer a difference 
between shControl (shCtrl) and shLRP130 cells (data not shown), suggesting strong 
interplay between sirtuin 3 and LRP130. 2-way ANOVA with Bonferroni post test where 
indicated. (mean±s.e.m, *p<0.05). 
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Figure A.S9. Comparison of acetylated lysines in LRP130 (LRPPRC) across various 
studies. (A) Pair wise overlap of acetylated lysine sites in this study (Liu L) compared 
with other studies that ablated sirtuin 3 in cells or mouse liver. Gray indicates the number 
of unique acetylated lysine peptides of LRP130 (LRPPRC) identified in a particular 
study. Blue represents the number of peptides common between two studies. *Indicates a 
unique site identified across three separate studies. †indicates another unique site shared 
across three separate studies. Using a hypergeometric distribution, the probability that 
shared acetylated sites between two or more studies arose from a non-random (biological) 
process was greater than 80% across all studies (see materials and methods for 
mathematical formula and derivation used). (B) Acetylated lysine residues shared across 
studies shown in panel A. For simplicity, mouse residues are reported for all studies, 
irrespective of whether or not the study was performed using mouse or human samples. 
(C) Average IOD (integrated optical density) binding scores established by Smith BC et 
al 2011 (ACS Chem. Biol.) was compared across studies. A high score indicates greater 
affinity for SIRT3. 
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Figure A.S10. Mapping of the interaction between POLRMT and LRP130. (A) 
Immunoblot showing the interaction between in vitro translated POLRMT bearing a C-
terminal myc tag and purified LRP130 protein containing an S-Tag. (B) Immunoblot of 
various fragments of POLRMT and their level of interaction with S-tagged full length 
purified LRP130 protein. (C) Schematic summarizing the interactions shown in (B). 
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Figure A.S11. Knock-down of human LRP130 in 293T cells and reconstitution with 
mouse wild-type LRP130 or the LRP130 7KR mutant. (A) Using retrovirus, human 
LRP130 was stably knocked-down in 293T cells. The shRNA construct targeting human 
LRP130 does not affect murine LRP130 (data not shown). (B) Immunoblot confirming 
greater than 95% knock down of human LRP130. (C) As expected, 293T cells deficient 
for LRP130 have reduced expression of mitochondrially encoded genes. (D) Transient 
transfection of LacZ, murine wild-type LRP130 or the 7KR into 293T cells lacking 
human LRP130. A long exposure permitted comparison of the level of ectopically 
expressed murine LRP130 compared with the remaining endogenous human LRP130. 
Based on the knock-down of human LRP130, reconstitution with murine LRP130 is 
within a physiological range. (E) Fluorescent assessment of mitochondrial content using 
MitoTracker Green FM (n=3). (F) Genetic assessment of mitochondrial content using 
mitochondrial DNA content (n=3). For gene expression, Two-way ANOVA. For 
mitochondrial content, two-tailed unpaired Student’s t test. (mean+s.e.m, ***p<0.001). 
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Figure A.S12. Knock-down of human LRP130 in 293T cells and reconstitution with 
mouse wild-type LRP130 or the LRP130 7KQ mutant. (A) Using transient 
transfection of a plasmid bearing a shRNA construct targeted to human LRP130, human 
LRP130 was knocked down in 293T cells. The shRNA construct targeting human 
LRP130 does not affect murine Lrp130 (data not shown). (B) Immunoblot confirming 
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knock-down of human LRP130. (C) As expected, 293T cells deficient for LRP130 have 
reduced expression of mitochondrially encoded genes (n=3). (D) Gene expression 
following transient transfection of LacZ, murine wild-type LRP130, 7KR mutant and the 
7KQ mutant into 293T cells deficient for human LRP130 (n=3). (E) A long exposure 
immunoblot permitted comparison of the level of ectopically expressed murine LRP130 
compared with remaining endogenous human LRP130. 
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Table A.S1. Mass spectrometry intensities for lysines in murine LRP130 sensitive to 
deacetylation by SIRT3 
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Shown in columns 2 and 3 are mass spectrometry intensities for lysines in murine 
LRP130 sensitive to deacetylation by SIRT3, that is, those sites showing less than 50% 
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acetylation when treated with SIRT3 and NAD
+
. ‘Rel Ac’ denotes relative acetylation, 
derived by dividing the intensity of the SIRT3 sample by the acetylated control sample 
(Ac-Ctrl). Bolded lysine positions in column 1 were mutated in this study, generating a 
7KR LRP130 mutant. Highlighted in light gray are lysine residues in mouse and various 
other species. In some species, lysine residues were replaced with arginine residues, 
which mimic deacetylation and are highlighted in dark gray. 
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Table A.S2. Mouse primers used for RT-qPCR. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Where indicated official gene symbols are shown in brackets. 
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Table A.S3. Human primers used for RT-qPCR 
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